{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:12:30Z","timestamp":1788880350788,"version":"build-2803163510"},"reference-count":332,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08763-1","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:45:27Z","timestamp":1786632327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-dimensional spheroid models in breast cancer: tumor microenvironment complexity, cancer stem cell-driven resistance, and translational model integration"],"prefix":"10.1186","volume":"24","author":[{"given":"Yasmine K.","family":"Douglas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8349-6202","authenticated-orcid":false,"given":"Sirin A.","family":"Adham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"1","key":"8763_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal JAC. Cancer statistics, 2021. CA Cancer J Clinicians. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA Cancer J Clinicians"},{"issue":"10512","key":"8763_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","volume":"406","author":"LM Force","year":"2025","unstructured":"Force LM, Kocarnik JM, May ML, Bhangdia K, Crist A, Penberthy L, et al. The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the global burden of disease study 2023. Lancet. 2025;406(10512):1565\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(25)01635-6.","journal-title":"Lancet"},{"issue":"28","key":"8763_CR3","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1038\/onc.2014.314","volume":"34","author":"P Ramos","year":"2015","unstructured":"Ramos P, Bentires-Alj M. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance. Oncogene. 2015;34(28):3617\u201326. https:\/\/doi.org\/10.1038\/onc.2014.314.","journal-title":"Oncogene"},{"issue":"2","key":"8763_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","volume":"20","author":"CH Wong","year":"2019","unstructured":"Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019;20(2):273\u201386. https:\/\/doi.org\/10.1093\/biostatistics\/kxx069.","journal-title":"Biostatistics"},{"key":"8763_CR5","doi-asserted-by":"publisher","unstructured":"Salinas-Vera YM, Vald\u00e9s J, P\u00e9rez-Navarro Y, Mandujano-Lazaro G, Marchat LA, Ramos-Pay\u00e1n R, et al. Three-dimensional 3D culture models in gynecological and breast cancer research. Front Oncol. 2022;12:- 2022. https:\/\/doi.org\/10.3389\/fonc.2022.826113.","DOI":"10.3389\/fonc.2022.826113"},{"issue":"10","key":"8763_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrm2236","volume":"8","author":"F Pampaloni","year":"2007","unstructured":"Pampaloni F, Reynaud EG, Stelzer EHK. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8(10):839\u201345. https:\/\/doi.org\/10.1038\/nrm2236.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8763_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2019.11.005","volume":"85-86","author":"M Urbanczyk","year":"2020","unstructured":"Urbanczyk M, Layland SL, Schenke-Layland K. The role of extracellular matrix in biomechanics and its impact on bioengineering of cells and 3D tissues. Matrix Biol: J Int Soc Matrix Biol. 2020;85-86:1\u201314. https:\/\/doi.org\/10.1016\/j.matbio.2019.11.005.","journal-title":"Matrix Biol: J Int Soc Matrix Biol"},{"issue":"1","key":"8763_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald LB, Bellet D, Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia (New Y, NY). 2015;17(1):1\u201315. https:\/\/doi.org\/10.1016\/j.neo.2014.12.004.","journal-title":"Neoplasia (New Y, NY)"},{"issue":"24","key":"8763_CR9","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1242\/jcs.017640","volume":"120","author":"T Mseka","year":"2007","unstructured":"Mseka T, Bamburg JR, Cramer LP. ADF\/cofilin family proteins control formation of oriented actin-filament bundles in the cell body to trigger fibroblast polarization. J Cell Sci. 2007;120(24):4332\u201344. https:\/\/doi.org\/10.1242\/jcs.017640.","journal-title":"J Cell Sci"},{"issue":"17","key":"8763_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cells14171351","volume":"14","author":"NE Koletsis","year":"2025","unstructured":"Koletsis NE, Mangani S, Franchi M, Piperigkou Z, Karamanos NK. Development, functional characterization, and matrix effectors dynamics in 3D spheroids of triple-negative breast cancer cells. Cells. 2025;14(17):1351. https:\/\/doi.org\/10.3390\/cells14171351.","journal-title":"Cells"},{"issue":"1","key":"8763_CR11","doi-asserted-by":"publisher","first-page":"19506","DOI":"10.1038\/s41598-025-03504-8","volume":"15","author":"P Guerrero-L\u00f3pez","year":"2025","unstructured":"Guerrero-L\u00f3pez P, Mart\u00edn-Pardillos A, Bonet-Aleta J, Mosseri A, Hueso JL, Santamaria J, et al. 2D versus 3D tumor-on-chip models to study the impact of tumor organization on metabolic patterns in vitro. Sci Rep. 2025;15(1):19506. https:\/\/doi.org\/10.1038\/s41598-025-03504-8.","journal-title":"Sci Rep"},{"issue":"8","key":"8763_CR12","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.7150\/thno.127053","volume":"16","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Payab N, Weigelin B, Sch\u00fcrch CM. From 2D cultures to 3D systems: evolving cancer models at the interface of functional precision medicine and theranostics. Theranostics. 2026;16(8):4042. https:\/\/doi.org\/10.7150\/thno.127053.","journal-title":"Theranostics"},{"key":"8763_CR13","doi-asserted-by":"publisher","first-page":"1498141","DOI":"10.3389\/fbioe.2025.1498141","volume":"13","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Yu F, Guo M, Tang Y, Xu Q. Bridging the gap: the role of 3D cell cultures in mimicking tumor microenvironment for enhanced drug testing accuracy. Front Bioeng Biotechnol. 2025;13:1498141. https:\/\/doi.org\/10.3389\/fbioe.2025.1498141.","journal-title":"Front Bioeng Biotechnol"},{"key":"8763_CR14","doi-asserted-by":"crossref","unstructured":"Tutty MA, Holmes S, Prina-Mello A. Cancer cell culture: the basics and two-dimensional cultures. In: Cancer cell culture: methods and protocols. Springer; 2023. p. 3\u201340.","DOI":"10.1007\/978-1-0716-3056-3_1"},{"issue":"4","key":"8763_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/cancers13040874","volume":"13","author":"S Gunti","year":"2021","unstructured":"Gunti S, Hoke ATK, Vu KP, London NR Jr. Organoid and spheroid tumor models: techniques and applications. Cancers. 2021;13(4):874. https:\/\/doi.org\/10.3390\/cancers13040874.","journal-title":"Cancers"},{"issue":"19","key":"8763_CR16","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3390\/cancers15194846","volume":"15","author":"P Nayak","year":"2023","unstructured":"Nayak P, Bentivoglio V, Varani M, Signore A. Three-dimensional in vitro tumor spheroid models for evaluation of anticancer therapy: recent updates. Cancers (Basel). 2023;15(19):4846. https:\/\/doi.org\/10.3390\/cancers15194846.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8763_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-017-0570-9","volume":"36","author":"S Riffle","year":"2017","unstructured":"Riffle S, Hegde RS. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids. J Exp Clin Cancer Res. 2017;36(1):102. https:\/\/doi.org\/10.1186\/s13046-017-0570-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"8763_CR18","doi-asserted-by":"publisher","first-page":"1350935","DOI":"10.3389\/fonc.2024.1350935","volume":"14","author":"Y Shi","year":"2024","unstructured":"Shi Y, Guan Z, Cai G, Nie Y, Zhang C, Luo W, et al. Patient-derived organoids: a promising tool for breast cancer research. Front Oncol. 2024;14:1350935. https:\/\/doi.org\/10.3389\/fonc.2024.1350935.","journal-title":"Front Oncol"},{"key":"8763_CR19","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.tranon.2024.102226","volume":"51","author":"S Taurin","year":"2025","unstructured":"Taurin S, Alzahrani R, Aloraibi S, Ashi L, Alharmi R, Hassani N. Patient-derived tumor organoids: a preclinical platform for personalized cancer therapy. Transl Oncol. 2025;51:102226. https:\/\/doi.org\/10.1016\/j.tranon.2024.102226.","journal-title":"Transl Oncol"},{"key":"8763_CR20","doi-asserted-by":"publisher","first-page":"1290504","DOI":"10.3389\/fimmu.2024.1290504","volume":"15","author":"L Guo","year":"2024","unstructured":"Guo L, Li C, Gong W. Toward reproducible tumor organoid culture: focusing on primary liver cancer. Front Immunol. 2024;15:1290504. https:\/\/doi.org\/10.3389\/fimmu.2024.1290504.","journal-title":"Front Immunol"},{"issue":"13","key":"8763_CR21","doi-asserted-by":"publisher","first-page":"14375","DOI":"10.1002\/cam4.5943","volume":"12","author":"C Zhou","year":"2023","unstructured":"Zhou C, Wu Y, Wang Z, Liu Y, Yu J, Wang W, et al. Standardization of organoid culture in cancer research. Cancer Med. 2023;12(13):14375\u201386. https:\/\/doi.org\/10.1002\/cam4.5943.","journal-title":"Cancer Med"},{"issue":"1","key":"8763_CR22","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/s41598-023-29060-7","volume":"13","author":"S Liu","year":"2023","unstructured":"Liu S, Yang W, Li Y, Sun C. Fetal bovine serum, an important factor affecting the reproducibility of cell experiments. Sci Rep. 2023;13(1):1942. https:\/\/doi.org\/10.1038\/s41598-023-29060-7.","journal-title":"Sci Rep"},{"issue":"5","key":"8763_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/cells14050336","volume":"14","author":"T Lebedev","year":"2025","unstructured":"Lebedev T, Mikheeva A, Gasca V, Spirin P, Prassolov V. Systematic comparison of FBS and medium variation effect on key cellular processes using morphological profiling. Cells. 2025;14(5):336. https:\/\/doi.org\/10.3390\/cells14050336.","journal-title":"Cells"},{"key":"8763_CR24","doi-asserted-by":"publisher","first-page":"213428","DOI":"10.1016\/j.bioadv.2023.213428","volume":"151","author":"AC Duarte","year":"2023","unstructured":"Duarte AC, Costa EC, Filipe HAL, Saraiva SM, Jacinto T, Miguel SP, et al. Animal-derived products in science and current alternatives. Biomater Adv. 2023;151:213428. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213428.","journal-title":"Biomater Adv"},{"issue":"4","key":"8763_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/organoids2040013","volume":"2","author":"RC Estridge","year":"2023","unstructured":"Estridge RC, O\u2019Neill JE, Keung AJ. Matrigel tunes H9 stem cell-derived human cerebral organoid development. Organoids. 2023;2(4):165\u201376. https:\/\/doi.org\/10.3390\/organoids2040013.","journal-title":"Organoids"},{"issue":"1","key":"8763_CR26","doi-asserted-by":"publisher","first-page":"2101085","DOI":"10.1002\/adhm.202101085","volume":"11","author":"E Prince","year":"2022","unstructured":"Prince E, Kheiri S, Wang Y, Xu F, Cruickshank J, Topolskaia V, et al. Microfluidic arrays of breast tumor spheroids for drug screening and personalized cancer therapies. Adv Healthcare Mater. 2022;11(1):2101085. https:\/\/doi.org\/10.1002\/adhm.202101085.","journal-title":"Adv Healthcare Mater"},{"key":"8763_CR27","doi-asserted-by":"publisher","unstructured":"Hogenson TL, Xie H, Phillips WJ, Toruner MD, Li JJ, Horn IP, et al. Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers. JCI Insight. 2022;7(22):e158060. https:\/\/doi.org\/10.1172\/jci.insight.158060.","DOI":"10.1172\/jci.insight.158060"},{"key":"8763_CR28","doi-asserted-by":"publisher","first-page":"1471012","DOI":"10.3389\/fbioe.2024.1471012","volume":"12","author":"C Bach","year":"2024","unstructured":"Bach C, Glasow A, Baran-Schmidt R, Oppermann H, Bach C, Meixensberger J, et al. Rapid and reproducible generation of glioblastoma spheroids for high-throughput drug screening. Front Bioeng Biotechnol. 2024;12:1471012. https:\/\/doi.org\/10.3389\/fbioe.2024.1471012.","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"8763_CR29","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/gels11070562","volume":"11","author":"I Sorzabal-Bellido","year":"2025","unstructured":"Sorzabal-Bellido I, Morales X, Cort\u00e9s-Dom\u00ednguez I, Esparza M, Grande L, Castillo P, et al. Tumor organoids grown in mixed-composition hydrogels recapitulate the plasticity of pancreatic cancers. Gels. 2025;11(7):562. https:\/\/doi.org\/10.3390\/gels11070562.","journal-title":"Gels"},{"issue":"1","key":"8763_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s44385-025-00041-x","volume":"2","author":"C Yadav","year":"2025","unstructured":"Yadav C, Evtushenko AS, Popov AB, Torres BL, Ahmed I, Dvinskikh L, et al. A 3D spheroid model for assessing nanocarrier-based drug delivery to solid tumors. Npj Biomed Innov. 2025;2(1):37. https:\/\/doi.org\/10.1038\/s44385-025-00041-x.","journal-title":"Npj Biomed Innov"},{"issue":"11\u201312","key":"8763_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/09553000701727531","volume":"83","author":"J Friedrich","year":"2007","unstructured":"Friedrich J, Ebner R, Kunz-Schughart LA. Experimental anti-tumor therapy in 3-D: spheroids \u2013 old hat or new challenge? Int J Radiat Biol. 2007;83(11\u201312):849\u201371. https:\/\/doi.org\/10.1080\/09553000701727531.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"8763_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-020-00931-0","volume":"13","author":"M Zanoni","year":"2020","unstructured":"Zanoni M, Cortesi M, Zamagni A, Arienti C, Pignatta S, Tesei A. Modeling neoplastic disease with spheroids and organoids. J Hematol Oncol. 2020;13(1):97. https:\/\/doi.org\/10.1186\/s13045-020-00931-0.","journal-title":"J Hematol Oncol"},{"key":"8763_CR33","doi-asserted-by":"publisher","unstructured":"Grimes DR, Fletcher AG, Partridge M. Oxygen consumption dynamics in steady-state tumour models. R Soc Open Sci. 2014;1(1). https:\/\/doi.org\/10.1098\/rsos.140080.","DOI":"10.1098\/rsos.140080"},{"issue":"4849","key":"8763_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1126\/science.2451290","volume":"240","author":"RM Sutherland","year":"1988","unstructured":"Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988;240(4849):177\u201384. https:\/\/doi.org\/10.1126\/science.2451290.","journal-title":"Science"},{"issue":"5","key":"8763_CR35","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.62617\/mcb1246","volume":"22","author":"L Yu","year":"2025","unstructured":"Yu L, Ye Y, Liu H, Zang C, Eucker J. 3D cell culture is a highly effective method to collect breast cancer stem cells in vitro. Mcb. 2025;22(5):1246. https:\/\/doi.org\/10.62617\/mcb1246.","journal-title":"Mcb"},{"issue":"1","key":"8763_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13578-022-00887-3","volume":"12","author":"C Jubelin","year":"2022","unstructured":"Jubelin C, Mu\u00f1oz-Garcia J, Griscom L, Cochonneau D, Ollivier E, Heymann M-F, et al. Three-dimensional in vitro culture models in oncology research. Cell Biosci. 2022;12(1):155. https:\/\/doi.org\/10.1186\/s13578-022-00887-3.","journal-title":"Cell Biosci"},{"key":"8763_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.actbio.2018.05.034","volume":"75","author":"LP Ferreira","year":"2018","unstructured":"Ferreira LP, Gaspar VM, Mano JF. Design of spherically structured 3D in vitro tumor models -advances and prospects. Acta Biomater. 2018;75:11\u201334. https:\/\/doi.org\/10.1016\/j.actbio.2018.05.034.","journal-title":"Acta Biomater"},{"key":"8763_CR38","doi-asserted-by":"crossref","unstructured":"Parihar A, Choudhary NK, Parihar DS, Khan R. Tumor-on-a-chip: microfluidic models of hypoxic tumor microenvironment. In: Hypoxia in cancer: significance and impact on cancer. Therapy: Springer; 2023. p. 297\u2013328.","DOI":"10.1007\/978-981-99-0313-9_14"},{"issue":"6378","key":"8763_CR39","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fern\u00e1ndez-Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359(6378):920\u201326. https:\/\/doi.org\/10.1126\/science.aao2774.","journal-title":"Science"},{"issue":"1","key":"8763_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","volume":"31","author":"WH Abuwatfa","year":"2024","unstructured":"Abuwatfa WH, Pitt WG, Husseini GA. Scaffold-based 3D cell culture models in cancer research. J Biomed Sci. 2024;31(1):7. https:\/\/doi.org\/10.1186\/s12929-024-00994-y.","journal-title":"J Biomed Sci"},{"issue":"1","key":"8763_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2015.12.005","volume":"18","author":"X Yin","year":"2016","unstructured":"Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering stem cell organoids. Cell STEM Cell. 2016;18(1):25\u201338. https:\/\/doi.org\/10.1016\/j.stem.2015.12.005.","journal-title":"Cell STEM Cell"},{"issue":"4","key":"8763_CR42","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","volume":"14","author":"M Kapa\u0142czy\u0144ska","year":"2018","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V, et al. 2D and 3D cell cultures-a comparison of different types of cancer cell cultures. Arch Med Sci. 2018;14(4):910\u201319. https:\/\/doi.org\/10.5114\/aoms.2016.63743.","journal-title":"Arch Med Sci"},{"issue":"4","key":"8763_CR43","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3892\/or.2015.3767","volume":"33","author":"Y Imamura","year":"2015","unstructured":"Imamura Y, Mukohara T, Shimono Y, Funakoshi Y, Chayahara N, Toyoda M, et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol Rep. 2015;33(4):1837\u201343. https:\/\/doi.org\/10.3892\/or.2015.3767.","journal-title":"Oncol Rep"},{"issue":"1","key":"8763_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","volume":"148","author":"F Hirschhaeuser","year":"2010","unstructured":"Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol. 2010;148(1):3\u201315. https:\/\/doi.org\/10.1016\/j.jbiotec.2010.01.012.","journal-title":"J Biotechnol"},{"issue":"7391","key":"8763_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"C Begley","year":"2012","unstructured":"Begley C, Ellis L. Drug development: raise standards for preclinical cancer research. Nature.[online]. 2012;483(7391):531\u201333. https:\/\/doi.org\/10.1038\/483531a.","journal-title":"Nature.[online]"},{"issue":"3","key":"8763_CR46","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jacbts.2019.02.005","volume":"4","author":"GA Van Norman","year":"2019","unstructured":"Van Norman GA. Phase II trials in drug development and adaptive trial design. JACC: Basic To Transl Sci. 2019;4(3):428\u201337. https:\/\/doi.org\/10.1016\/j.jacbts.2019.02.005.","journal-title":"JACC: Basic To Transl Sci"},{"issue":"10","key":"8763_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/ijms26104572","volume":"26","author":"A Ciringione","year":"2025","unstructured":"Ciringione A, Rizzi F. Facing the challenge to mimic breast cancer heterogeneity: established and emerging experimental preclinical models integrated with omics technologies. IJMS. 2025;26(10):26. https:\/\/doi.org\/10.3390\/ijms26104572.","journal-title":"IJMS"},{"issue":"1","key":"8763_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41598-025-87622-3","volume":"15","author":"S Noman","year":"2025","unstructured":"Noman S, Fadel Y, Henedak M, Attia N, Essam M, Elmaasarawii S, et al. Leveraging survival analysis and machine learning for accurate prediction of breast cancer recurrence and metastasis. Sci Rep. 2025;15(1):15. https:\/\/doi.org\/10.1038\/s41598-025-87622-3.","journal-title":"Sci Rep"},{"issue":"3","key":"8763_CR49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1470-2045(25)00730-2","volume":"27","author":"K Bhangdia","year":"2026","unstructured":"Bhangdia K, May ML, Kocarnik JM, Pritchett N, Crist A, Penberthy L, et al. Global, regional, and national burden of breast cancer among females, 1990\u20132023, with forecasts to 2050: a systematic analysis for the global burden of disease study 2023. The Lancet Oncol. 2026;27(3):302\u201326. https:\/\/doi.org\/10.1016\/S1470-2045(25)00730-2.","journal-title":"The Lancet Oncol"},{"issue":"1","key":"8763_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12911-023-02377-z","volume":"23","author":"D Zuo","year":"2023","unstructured":"Zuo D, Yang L, Jin Y, Qi H, Liu Y, Ren L. Machine learning-based models for the prediction of breast cancer recurrence risk. BMC Med Inf Decis Mak. 2023;23(1):23. https:\/\/doi.org\/10.1186\/s12911-023-02377-z.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"8763_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-022-00363-1","volume":"12","author":"L Guo","year":"2023","unstructured":"Guo L, Kong D, Liu J, Zhan L, Luo L, Zheng W, et al. Breast cancer heterogeneity and its implication in personalized precision therapy. Exp Hematol Oncol. 2023;12(1):12. https:\/\/doi.org\/10.1186\/s40164-022-00363-1.","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"8763_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers12051239","volume":"12","author":"R Vikram","year":"2020","unstructured":"Vikram R, Chou W-C, Hung S, Shen C-Y. Tumorigenic and metastatic role of CD44\u2212\/low\/CD24\u2212\/low cells in luminal breast cancer. Cancers. 2020;12(5):12. https:\/\/doi.org\/10.3390\/cancers12051239.","journal-title":"Cancers"},{"issue":"34","key":"8763_CR53","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741\u201351. https:\/\/doi.org\/10.1038\/onc.2010.215.","journal-title":"Oncogene"},{"issue":"1","key":"8763_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25(1):20. https:\/\/doi.org\/10.1186\/s12929-018-0426-4.","journal-title":"J Biomed Sci"},{"key":"8763_CR55","doi-asserted-by":"publisher","unstructured":"Hermawan A, Putri H, Fatimah N, Prasetio HH. Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells. Heliyon. 2024;10(2):e24356. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24356.","DOI":"10.1016\/j.heliyon.2024.e24356"},{"issue":"1","key":"8763_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Wang Z, Ajani JA, Song S. Drug resistance and cancer stem cells. Cell Commun Signal. 2021;19(1):19. https:\/\/doi.org\/10.1186\/s12964-020-00627-5.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"8763_CR57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13287-025-04218-4","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, Xu S, Yin C, Hu S, Liu P. The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials. STEM Cell Res Ther. 2025;16(1):156. https:\/\/doi.org\/10.1186\/s13287-025-04218-4.","journal-title":"STEM Cell Res Ther"},{"issue":"5","key":"8763_CR58","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cpt.2025.01.006","volume":"3","author":"PL Teoh","year":"2025","unstructured":"Teoh PL, Saini N. Biomarkers, isolation methods, and therapeutic implications of breast cancer stem cells. Cancer Pathogen Ther. 2025;3(5):392\u2013401. https:\/\/doi.org\/10.1016\/j.cpt.2025.01.006.","journal-title":"Cancer Pathogen Ther"},{"issue":"1","key":"8763_CR59","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12935-022-02841-2","volume":"22","author":"A-RN Zekri","year":"2022","unstructured":"Zekri A-RN, Bahnassy A, Mourad M, Malash I, Ahmed O, Abdellateif MS. Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients. Cancer Cell Int. 2022;22(1):423. https:\/\/doi.org\/10.1186\/s12935-022-02841-2.","journal-title":"Cancer Cell Int"},{"key":"8763_CR60","doi-asserted-by":"publisher","first-page":"1026278","DOI":"10.3389\/fonc.2022.1026278","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Li Y, Chen Y, Liu P, Huang S, Zhang Y, et al. ALDH1: a potential therapeutic target for cancer stem cells in solid tumors. Front Oncol. 2022;12:1026278. https:\/\/doi.org\/10.3389\/fonc.2022.1026278.","journal-title":"Front Oncol"},{"issue":"43","key":"8763_CR61","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41388-024-03156-4","volume":"43","author":"W Fernando","year":"2024","unstructured":"Fernando W, Cruickshank BM, Arun RP, MacLean MR, Cahill HF, Morales-Quintanilla F, et al. ALDH1A3 is the switch that determines the balance of ALDH+ and CD24\u2212 CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer. Oncogene. 2024;43(43):3151\u201369. https:\/\/doi.org\/10.1038\/s41388-024-03156-4.","journal-title":"Oncogene"},{"issue":"6","key":"8763_CR62","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/cells11060934","volume":"11","author":"I Conde","year":"2022","unstructured":"Conde I, Ribeiro AS, Paredes J. Breast cancer stem cell membrane biomarkers: therapy targeting and clinical implications. Cells. 2022;11(6):934. https:\/\/doi.org\/10.3390\/cells11060934.","journal-title":"Cells"},{"key":"8763_CR63","doi-asserted-by":"crossref","unstructured":"Nandi A, Chakrabarti R. Assessment of breast cancer stem cell activity using a spheroid formation assay. Methods in molecular biology. Vol. 2429. Clifton, NJ; 2022. p. 485\u2013500.","DOI":"10.1007\/978-1-0716-1979-7_33"},{"issue":"1","key":"8763_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s43046-022-00152-1","volume":"34","author":"JM Ambrose","year":"2022","unstructured":"Ambrose JM, Veeraraghavan VP, Vennila R, Rupert S, Sathyanesan J, Meenakshisundaram R, et al. Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line. J Egypt Natl Canc Inst. 2022;34(1):51. https:\/\/doi.org\/10.1186\/s43046-022-00152-1.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"2","key":"8763_CR65","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ijc.34931","volume":"155","author":"H Wu","year":"2024","unstructured":"Wu H, Wang W, Zhang Y, Chen Y, Shan C, Li J, et al. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients. Intl J Cancer. 2024;155(2):324\u201338. https:\/\/doi.org\/10.1002\/ijc.34931.","journal-title":"Intl J Cancer"},{"issue":"2","key":"8763_CR66","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","volume":"164","author":"G Mehta","year":"2012","unstructured":"Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release. 2012;164(2):192\u2013204. https:\/\/doi.org\/10.1016\/j.jconrel.2012.04.045.","journal-title":"J Control Release"},{"issue":"21","key":"8763_CR67","doi-asserted-by":"publisher","first-page":"27151","DOI":"10.1021\/acsami.4c04135","volume":"16","author":"P Gonz\u00e1lez-Callejo","year":"2024","unstructured":"Gonz\u00e1lez-Callejo P, Garc\u00eda-Astrain C, Herrero-Ruiz A, Henriksen-Lacey M, Seras-Franzoso J, Abasolo I, et al. 3D bioprinted tumor-stroma models of triple-negative breast cancer stem cells for preclinical targeted therapy evaluation. ACS Appl. Mater. Interface. 2024;16(21):27151\u201363. https:\/\/doi.org\/10.1021\/acsami.4c04135.","journal-title":"ACS Appl. Mater. Interface"},{"issue":"1","key":"8763_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-024-00960-8","volume":"48","author":"J Kalla","year":"2025","unstructured":"Kalla J, Pfneissl J, Mair T, Tran L, Egger G. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine. Cell Oncol. 2025;48(1):1\u201326. https:\/\/doi.org\/10.1007\/s13402-024-00960-8.","journal-title":"Cell Oncol"},{"issue":"1","key":"8763_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41598-017-10863-4","volume":"7","author":"D Reynolds","year":"2017","unstructured":"Reynolds D, Tevis K, Blessing W, Colson Y, Zaman M, Grinstaff M. Breast cancer spheroids reveal a differential cancer stem cell response to chemotherapeutic treatment. Sci Rep. 2017;7(1):7. https:\/\/doi.org\/10.1038\/s41598-017-10863-4.","journal-title":"Sci Rep"},{"issue":"1","key":"8763_CR70","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13058-024-01931-5","volume":"26","author":"RK Przanowska","year":"2024","unstructured":"Przanowska RK, Labban N, Przanowski P, Hawes RB, Atkins KA, Showalter SL, et al. Patient-derived response estimates from zero-passage organoids of luminal breast cancer. Breast Cancer Res. 2024;26(1):192. https:\/\/doi.org\/10.1186\/s13058-024-01931-5.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"8763_CR71","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ijc.34945","volume":"155","author":"Y-Y Lin","year":"2024","unstructured":"Lin Y-Y, Gao H-F, Li H, Hu Q, Du B-L, Li S, et al. Clinical efficacy of tumor organoid-guided cancer therapy for locally advanced unresectable or metastatic breast cancer. Intl J Cancer. 2024;155(4):697\u2013709. https:\/\/doi.org\/10.1002\/ijc.34945.","journal-title":"Intl J Cancer"},{"issue":"8","key":"8763_CR72","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41578-018-0034-7","volume":"3","author":"B Zhang","year":"2018","unstructured":"Zhang B, Korolj A, Lai BFL, Radisic M. Advances in organ-on-a-chip engineering. Nat Rev Mater. 2018;3(8):257\u201378. https:\/\/doi.org\/10.1038\/s41578-018-0034-7.","journal-title":"Nat Rev Mater"},{"issue":"4","key":"8763_CR73","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41551-019-0471-7","volume":"4","author":"SV Murphy","year":"2019","unstructured":"Murphy SV, De Coppi P, Atala A. Opportunities and challenges of translational 3D bioprinting. Nat Biomed Eng. 2019;4(4):370\u201380. https:\/\/doi.org\/10.1038\/s41551-019-0471-7.","journal-title":"Nat Biomed Eng"},{"issue":"18","key":"8763_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/adhm.202202609","volume":"12","author":"W Li","year":"2023","unstructured":"Li W, Zhou Z, Zhou X, Khoo B, Gunawan R, Chin Y, et al. 3D biomimetic models to reconstitute tumor microenvironment in vitro: spheroids, organoids, and tumor-on-a-Chip. Adv Healthcare Mater. 2023;12(18):12. https:\/\/doi.org\/10.1002\/adhm.202202609.","journal-title":"Adv Healthcare Mater"},{"issue":"3","key":"8763_CR75","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009;4(3):309\u201324. https:\/\/doi.org\/10.1038\/nprot.2008.226.","journal-title":"Nat Protoc"},{"issue":"11","key":"8763_CR76","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1038\/nprot.2012.127","volume":"7","author":"RS Fischer","year":"2012","unstructured":"Fischer RS, Myers KA, Gardel ML, Waterman CM. Stiffness-controlled three-dimensional extracellular matrices for high-resolution imaging of cell behavior. Nat Protoc. 2012;7(11):2056\u201366. https:\/\/doi.org\/10.1038\/nprot.2012.127.","journal-title":"Nat Protoc"},{"issue":"5","key":"8763_CR77","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000529431","volume":"212","author":"S Yip","year":"2023","unstructured":"Yip S, Wang N, Sugimura R. Give them vasculature and immune cells \u2013 how to fill the gap of organoids. Cells Tissues Organs. 2023;212(5):369\u201382. https:\/\/doi.org\/10.1159\/000529431.","journal-title":"Cells Tissues Organs"},{"key":"8763_CR78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bioactmat.2024.08.037","volume":"42","author":"T D\u00e9sigaux","year":"2024","unstructured":"D\u00e9sigaux T, Comperat L, Dusserre N, Stachowicz M, Lea M, Dupuy J-W, et al. 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity. Bioact Mater. 2024;42:316\u201327. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.08.037.","journal-title":"Bioact Mater"},{"key":"8763_CR79","doi-asserted-by":"publisher","unstructured":"Gurung S, Berger K, Rao RS. TMIC-48. THREE DIMENSIONAL CANCER CELL-MONOCYTE CO-CULTURE SPHEROIDS RECAPITULATE IMMUNOSUPPRESSIVE AND PRO-TUMORIGENIC MICROENVIRONMENTS IN BRAIN METASTATIC BREAST CANCER. Neuro-Oncology. 2024;26(Supplement_8):viii309\u2013309. https:\/\/doi.org\/10.1093\/neuonc\/noae165.1226.","DOI":"10.1093\/neuonc\/noae165.1226"},{"key":"8763_CR80","doi-asserted-by":"publisher","first-page":"603640","DOI":"10.3389\/fimmu.2020.603640","volume":"11","author":"N Boucherit","year":"2020","unstructured":"Boucherit N, Gorvel L, Olive D. 3D tumor models and their use for the testing of immunotherapies. Front Immunol. 2020;11:603640. https:\/\/doi.org\/10.3389\/fimmu.2020.603640.","journal-title":"Front Immunol"},{"key":"8763_CR81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bios.2018.03.058","volume":"110","author":"L Hu","year":"2018","unstructured":"Hu L, Ge A, Wang X, Wang S, Yue X, Wang J, et al. Real-time monitoring of immune responses under pathogen invasion and drug interference by integrated microfluidic device coupled with worm-based biosensor. Biosens Bioelectron. 2018;110:233\u201338. https:\/\/doi.org\/10.1016\/j.bios.2018.03.058.","journal-title":"Biosens Bioelectron"},{"key":"8763_CR82","doi-asserted-by":"publisher","unstructured":"Bregenzer ME, Davis C, Horst EN, Mehta P, Novak CM, Raghavan S, et al. Physiologic patient derived 3D spheroids for Anti-neoplastic Drug screening to target cancer stem cells. J Visualized Experiments: JoVE. 2019;149(149). https:\/\/doi.org\/10.3791\/59696.","DOI":"10.3791\/59696"},{"key":"8763_CR83","doi-asserted-by":"publisher","first-page":"213915","DOI":"10.1016\/j.bioadv.2024.213915","volume":"162","author":"S Jeibouei","year":"2024","unstructured":"Jeibouei S, Monfared AK, Hojat A, Aref A, Shams F, Dolati M, et al. Human-derived tumor-on-chip model to study the heterogeneity of breast cancer tissue. Biomater Adv. 2024;162:213915. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213915.","journal-title":"Biomater Adv"},{"issue":"1","key":"8763_CR84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1087057112456874","volume":"18","author":"E Krausz","year":"2013","unstructured":"Krausz E, de Hoogt R, Gustin E, Cornelissen F, Grand-Perret T, Janssen L, et al. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening. SLAS Discov. 2013;18(1):54\u201366. https:\/\/doi.org\/10.1177\/1087057112456874.","journal-title":"SLAS Discov"},{"issue":"5","key":"8763_CR85","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1021\/acsami.4c19291","volume":"17","author":"M Hong","year":"2025","unstructured":"Hong M, Hong S, Song J. 3D bioprinted multidrug resistance (MDR)-dependent tumor spheroids. ACS Appl. Mater. Interface. 2025;17(5):7377\u201394. https:\/\/doi.org\/10.1021\/acsami.4c19291.","journal-title":"ACS Appl. Mater. Interface"},{"key":"8763_CR86","doi-asserted-by":"publisher","unstructured":"Ungrin MD, Joshi C, Nica A, Bauwens C, Zandstra PW. Reproducible, ultra High-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One. 2008;3(2):e 1565. https:\/\/doi.org\/10.1371\/journal.pone.0001565.","DOI":"10.1371\/journal.pone.0001565"},{"key":"8763_CR87","doi-asserted-by":"crossref","unstructured":"Luo M, Clouthier SG, Deol Y, Liu S, Nagrath S, Azizi E, et al. Breast cancer stem cells: current advances and clinical implications. Mammary STEM Cells: Methods Protocol. 2015;1\u201349.","DOI":"10.1007\/978-1-4939-2519-3_1"},{"issue":"5","key":"8763_CR88","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.7150\/jca.94822","volume":"16","author":"R Zhou","year":"2025","unstructured":"Zhou R, Zhang Y, Xu L, Sun Y. Stigmasterol attenuates triple-negative breast cancer stem cell properties by inhibiting JAK3. J Cancer. 2025;16(5):1618\u201330. https:\/\/doi.org\/10.7150\/jca.94822.","journal-title":"J Cancer"},{"issue":"15","key":"8763_CR89","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.3390\/ijms26157503","volume":"26","author":"KN Ncube","year":"2025","unstructured":"Ncube KN, van den Bout I, Willers C, Gouws C, Cordier W. Utility of multicellular spheroids for investigating mechanisms of chemoresistance in triple-negative breast cancer. IJMS. 2025;26(15):7503. https:\/\/doi.org\/10.3390\/ijms26157503.","journal-title":"IJMS"},{"issue":"1","key":"8763_CR90","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1038\/s41598-025-90689-7","volume":"15","author":"S Sueoka","year":"2025","unstructured":"Sueoka S, Kai A, Kobayashi Y, Ito M, Sasada S, Emi A, et al. Diversity of ER-positive and HER2-negative breast cancer stem cells attained using selective culture techniques. Sci Rep. 2025;15(1):8257. https:\/\/doi.org\/10.1038\/s41598-025-90689-7.","journal-title":"Sci Rep"},{"key":"8763_CR91","doi-asserted-by":"publisher","unstructured":"Hwang-Verslues WW, Kuo W-H, Chang P-H, Pan C-C, Wang H-H, Tsai S-T, et al. Multiple lineages of human breast cancer stem\/progenitor cells identified by profiling with stem cell markers. PLoS One. 2009;4(12):e 8377. https:\/\/doi.org\/10.1371\/journal.pone.0008377.","DOI":"10.1371\/journal.pone.0008377"},{"issue":"2","key":"8763_CR92","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jcb.26298","volume":"119","author":"CE Rodr\u00edguez","year":"2018","unstructured":"Rodr\u00edguez CE, Berardi DE, Abrigo M, Todaro LB, Bal de Kier Joffe ED, Fiszman GL. Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture. J Cellular Biochem. 2018;119(2):1381\u201391. https:\/\/doi.org\/10.1002\/jcb.26298.","journal-title":"J Cellular Biochem"},{"issue":"12","key":"8763_CR93","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1096\/fj.201801013R","volume":"32","author":"T Tang","year":"2018","unstructured":"Tang T, Yang Z, Zhu Q, Wu Y, Sun K, Alahdal M, et al. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cell metastasis, proliferation, and self-renewal by targeting E-cadherin. Faseb J. 2018;32(12):6965\u201381. https:\/\/doi.org\/10.1096\/fj.201801013R.","journal-title":"Faseb J"},{"issue":"1","key":"8763_CR94","doi-asserted-by":"publisher","first-page":"41237","DOI":"10.1038\/s41598-025-25202-1","volume":"15","author":"M Mazloomi","year":"2025","unstructured":"Mazloomi M, Hamishehkar H, Jahanban Esfahlan R. SpheroidSync as edge cutting transfer strategy for uniform and robust MCF7 spheroids in 3D culture. Sci Rep. 2025;15(1):41237. https:\/\/doi.org\/10.1038\/s41598-025-25202-1.","journal-title":"Sci Rep"},{"issue":"8","key":"8763_CR95","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/bjc.2014.105","volume":"110","author":"Y Liu","year":"2014","unstructured":"Liu Y, Nenutil R, Appleyard M, Murray K, Boylan M, Thompson A, et al. Lack of correlation of stem cell markers in breast cancer stem cells. Br J Cancer. 2014;110(8):2063\u201371. https:\/\/doi.org\/10.1038\/bjc.2014.105.","journal-title":"Br J Cancer"},{"issue":"8","key":"8763_CR96","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1158\/0008-5472.CAN-23-4022","volume":"85","author":"EP Souto","year":"2025","unstructured":"Souto EP, Gong P, Landua JD, Rajaram Srinivasan R, Ganesan A, Dobrolecki LE, et al. Lineage tracing and single-cell RNA sequencing reveal a common transcriptional state in breast cancer tumor\u2013initiating cells characterized by IFN\/STAT1 activity. Cancer Res. 2025;85(8):1390\u2013409. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-4022.","journal-title":"Cancer Res"},{"key":"8763_CR97","doi-asserted-by":"publisher","unstructured":"Grosse-Wilde A, Fouquier d\u2019 H\u00e9rou\u00ebl A, McIntosh E, Ertaylan G, Skupin A, Kuestner RE, et al. Stemness of the hybrid Epithelial\/Mesenchymal state in breast cancer and its association with poor survival. PLoS One. 2015;10(5):e0126522. https:\/\/doi.org\/10.1371\/journal.pone.0126522.","DOI":"10.1371\/journal.pone.0126522"},{"key":"8763_CR98","doi-asserted-by":"publisher","first-page":"150765","DOI":"10.1016\/j.bbrc.2024.150765","volume":"734","author":"MP Moreira","year":"2024","unstructured":"Moreira MP, Franco EP, Barros BAF, Anjos BRD, Almada DDG, Barbosa INT, et al. Standard chemotherapy impacts on in vitro cellular heterogeneity in spheroids enriched with cancer stem cells (CSCs) derived from triple-negative breast cancer cell line. Biochem Bioph Res Co. 2024;734:150765. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150765.","journal-title":"Biochem Bioph Res Co"},{"issue":"1","key":"8763_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4252\/wjsc.v7.i1.27","volume":"7","author":"MC Cabrera","year":"2015","unstructured":"Cabrera MC. Cancer stem cell plasticity and tumor hierarchy. WJSC. 2015;7(1):27. https:\/\/doi.org\/10.4252\/wjsc.v7.i1.27.","journal-title":"WJSC"},{"issue":"7","key":"8763_CR100","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4252\/wjsc.v13.i7.934","volume":"13","author":"V Kaushik","year":"2021","unstructured":"Kaushik V, Kulkarni Y, Felix K, Azad N, Iyer AKV, Yakisich JS. Alternative models of cancer stem cells: the stemness phenotype model, 10 years later. WJSC. 2021;13(7):934. https:\/\/doi.org\/10.4252\/wjsc.v13.i7.934.","journal-title":"WJSC"},{"key":"8763_CR101","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fimmu.2024.1503021","volume":"15","author":"L Li","year":"2025","unstructured":"Li L, Tang Y, Qiu L, Li Z, Wang R. Extracellular matrix shapes cancer stem cell behavior in breast cancer: a mini review. Front. Immunol. 2025;15:15. https:\/\/doi.org\/10.3389\/fimmu.2024.1503021.","journal-title":"Front. Immunol"},{"issue":"7","key":"8763_CR102","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.trecan.2020.12.014","volume":"7","author":"LP Ferguson","year":"2021","unstructured":"Ferguson LP, Diaz E, Reya T. The role of the microenvironment and immune system in regulating stem cell fate in cancer. Trends Cancer. 2021;7(7):624\u201334. https:\/\/doi.org\/10.1016\/j.trecan.2020.12.014.","journal-title":"Trends Cancer"},{"key":"8763_CR103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2021.06.015","volume":"82","author":"Z Hua","year":"2022","unstructured":"Hua Z, White J, Zhou J. Cancer stem cells in TNBC. Semin Cancer Biol. 2022;82:26\u201334. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.015.","journal-title":"Semin Cancer Biol"},{"key":"8763_CR104","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mtbio.2021.100155","volume":"12","author":"M Rabionet","year":"2021","unstructured":"Rabionet M, Polonio-Alcal\u00e1 E, Relat J, Yeste M, Sims-Mourtada J, Kloxin A, et al. Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds. Mater Today Bio. 2021;12:12. https:\/\/doi.org\/10.1016\/j.mtbio.2021.100155.","journal-title":"Mater Today Bio"},{"issue":"5","key":"8763_CR105","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","volume":"51","author":"M Katoh","year":"2017","unstructured":"Katoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (review). Int J Oncol. 2017;51(5):1357\u201369. https:\/\/doi.org\/10.3892\/ijo.2017.4129.","journal-title":"Int J Oncol"},{"issue":"6","key":"8763_CR106","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.kjms.2015.03.002","volume":"31","author":"S Saito","year":"2015","unstructured":"Saito S, Lin Y-C, Tsai M-H, Lin C-S, Murayama Y, Sato R, et al. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells. Kaohsiung J Med Scie. 2015;31(6):279\u201386. https:\/\/doi.org\/10.1016\/j.kjms.2015.03.002.","journal-title":"Kaohsiung J Med Scie"},{"issue":"2","key":"8763_CR107","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10549-010-1300-6","volume":"130","author":"PR Pandey","year":"2011","unstructured":"Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat. 2011;130(2):387\u201398. https:\/\/doi.org\/10.1007\/s10549-010-1300-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"8763_CR108","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/molecules24061027","volume":"24","author":"A Gir\u00f3-Perafita","year":"2019","unstructured":"Gir\u00f3-Perafita A, Rabionet M, Planas M, Feliu L, Ciurana J, Ruiz-Mart\u00ednez S, et al. EGCG-Derivative G28 shows high efficacy inhibiting the mammosphere-forming capacity of sensitive and resistant TNBC models. Molecules. 2019;24(6):1027. https:\/\/doi.org\/10.3390\/molecules24061027.","journal-title":"Molecules"},{"issue":"16","key":"8763_CR109","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.7150\/thno.41388","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Feng Z, He M-L. Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells. Theranostics. 2020;10(16):7053\u201369. https:\/\/doi.org\/10.7150\/thno.41388.","journal-title":"Theranostics"},{"key":"8763_CR110","doi-asserted-by":"crossref","unstructured":"Hong S, Song J. High-resolution in situ high-content imaging of 3D-Bioprinted single breast cancer spheroids for advanced quantification of Benzo(a)pyrene carcinogen-induced breast cancer stem cells. ACS applied materials & interfaces. 2023.","DOI":"10.1021\/acsami.2c17877"},{"issue":"8","key":"8763_CR111","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cancers12082290","volume":"12","author":"A Pal","year":"2020","unstructured":"Pal A, Ashworth J, Collier P, Probert C, Jones S, Leza EP, et al. A 3D heterotypic breast cancer Model demonstrates a role for mesenchymal stem cells in driving a proliferative and invasive phenotype. Cancers. 2020;12(8):12. https:\/\/doi.org\/10.3390\/cancers12082290.","journal-title":"Cancers"},{"issue":"10","key":"8763_CR112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms19103148","volume":"19","author":"E Polonio-Alcal\u00e1","year":"2018","unstructured":"Polonio-Alcal\u00e1 E, Rabionet M, Guerra A, Yeste M, Ciurana J, Puig T. Screening of additive manufactured scaffolds designs for triple negative breast cancer 3D cell culture and stem-like expansion. IJMS. 2018;19(10):19. https:\/\/doi.org\/10.3390\/ijms19103148.","journal-title":"IJMS"},{"issue":"1","key":"8763_CR113","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41598-025-92037-1","volume":"15","author":"S Zhu","year":"2025","unstructured":"Zhu S, Yin J, Lu X, Jiang D, Chen R, Cui K, et al. Influence of experimental variables on spheroid attributes. Sci Rep. 2025;15(1):15. https:\/\/doi.org\/10.1038\/s41598-025-92037-1.","journal-title":"Sci Rep"},{"key":"8763_CR114","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.actbio.2025.08.046","volume":"205","author":"CE Monette","year":"2025","unstructured":"Monette CE, Lee J, Peasah A, Sayles L, Tai M, Sweet-Cordero A, et al. Impact of scaffold material choice on osteosarcoma phenotype and drug responses in 3D. Acta Biomater. 2025;205:164\u201375. https:\/\/doi.org\/10.1016\/j.actbio.2025.08.046.","journal-title":"Acta Biomater"},{"issue":"2","key":"8763_CR115","doi-asserted-by":"publisher","first-page":"114666","DOI":"10.1016\/j.yexcr.2025.114666","volume":"450","author":"E Foster","year":"2025","unstructured":"Foster E, Wardhana O, Zeng Z, Lu X. Comparative analysis of 3D culture methodologies in prostate cancer cells. Exp Cell Res. 2025;450(2):114666. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114666.","journal-title":"Exp Cell Res"},{"issue":"11","key":"8763_CR116","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.3390\/cancers13112784","volume":"13","author":"RB Mokhtari","year":"2021","unstructured":"Mokhtari RB, Qorri B, Sambi M, Baluch N, Kumar S, Das B, et al. 3D multicellular stem-like human breast tumor spheroids enhance tumorigenicity of orthotopic xenografts in athymic nude rat Model. Cancers (Basel). 2021;13(11):2784. https:\/\/doi.org\/10.3390\/cancers13112784.","journal-title":"Cancers (Basel)"},{"key":"8763_CR117","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/978-1-0716-1979-7_32","volume":"2429","author":"A Ishtiah","year":"2022","unstructured":"Ishtiah A, Yahaya B. The enrichment of breast cancer stem cells from MCF7 breast cancer cell line using spheroid culture technique. Methods Mol Biol. 2022;2429:475\u201384.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"8763_CR118","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/cells8060621","volume":"8","author":"T Murayama","year":"2019","unstructured":"Murayama T, Gotoh N. Patient-derived xenograft models of breast cancer and their application. Cells. 2019;8(6):621. https:\/\/doi.org\/10.3390\/cells8060621.","journal-title":"Cells"},{"issue":"1","key":"8763_CR119","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","volume":"8","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Sig Transduct Target Ther. 2023;8(1):160. https:\/\/doi.org\/10.1038\/s41392-023-01419-2.","journal-title":"Sig Transduct Target Ther"},{"key":"8763_CR120","doi-asserted-by":"publisher","first-page":"204173142093340","DOI":"10.1177\/2041731420933407","volume":"11","author":"C Zhang","year":"2020","unstructured":"Zhang C, Yang Z, Dong D-L, Jang T-S, Knowles JC, Kim H-W, et al. 3D culture technologies of cancer stem cells: promising ex vivo tumor models. J Tissue Eng. 2020;11:2041731420933407. https:\/\/doi.org\/10.1177\/2041731420933407.","journal-title":"J Tissue Eng"},{"issue":"2","key":"8763_CR121","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10911-012-9258-0","volume":"17","author":"LM Rota","year":"2012","unstructured":"Rota LM, Lazzarino DA, Ziegler AN, LeRoith D, Wood TL. Determining mammosphere-forming potential: application of the limiting dilution analysis. J Mammary Gland Biol Neoplasia. 2012;17(2):119\u201323. https:\/\/doi.org\/10.1007\/s10911-012-9258-0.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"4","key":"8763_CR122","doi-asserted-by":"publisher","first-page":"427","DOI":"10.7150\/ijbs.12777","volume":"12","author":"L Boo","year":"2016","unstructured":"Boo L, Ho W, Ali NM, Yeap S, Ky H, Chan K-G, et al. MiRNA transcriptome profiling of spheroid-enriched cells with cancer stem cell properties in human breast MCF-7 cell line. Int J Biol Sci. 2016;12(4):427\u201345. https:\/\/doi.org\/10.7150\/ijbs.12777.","journal-title":"Int J Biol Sci"},{"key":"8763_CR123","doi-asserted-by":"publisher","unstructured":"Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+\/CD24- and CD133+cells with cancer stem cell characteristics. Breast Cancer Res. 2008;10(1):R10. https:\/\/doi.org\/10.1186\/bcr1855.","DOI":"10.1186\/bcr1855"},{"issue":"1","key":"8763_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10911-023-09540-2","volume":"28","author":"MMO Ortiz","year":"2023","unstructured":"Ortiz MMO, Andrechek ER. Molecular characterization and landscape of breast cancer models from a multi-omics perspective. J Mammary Gland Biol Neoplasia. 2023;28(1):12. https:\/\/doi.org\/10.1007\/s10911-023-09540-2.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"8763_CR125","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/life12020184","volume":"12","author":"A Herreros-Pomares","year":"2022","unstructured":"Herreros-Pomares A. Identification, culture and targeting of cancer stem cells. Life. 2022;12(2):184. https:\/\/doi.org\/10.3390\/life12020184.","journal-title":"Life"},{"key":"8763_CR126","doi-asserted-by":"crossref","unstructured":"Gil-Gas C, S\u00e1nchez-D\u00edez M, Honrubia-G\u00f3mez P, S\u00e1nchez-S\u00e1nchez JL, Alvarez-Sim\u00f3n C, Sabater S, et al. Self-renewal inhibition in breast cancer stem cells: moonlight role of PEDF in breast cancer. Cancers. 2023;15.","DOI":"10.21203\/rs.3.rs-2636130\/v1"},{"key":"8763_CR127","doi-asserted-by":"crossref","unstructured":"Memmi E, Sanarico A, Giacobbe A, Peschiaroli A, Frezza V, Cicalese A, et al. p63 sustains self-renewal of mammary cancer stem cells through regulation of sonic hedgehog signaling. Proceedings of the National Academy of Sciences. 2015: 3499\u2013504, 112.","DOI":"10.1073\/pnas.1500762112"},{"issue":"2","key":"8763_CR128","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/bcr1982","volume":"10","author":"C Fillmore","year":"2008","unstructured":"Fillmore C, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res: BCR. 2008;10(2):10. https:\/\/doi.org\/10.1186\/bcr1982.","journal-title":"Breast Cancer Res: BCR"},{"issue":"10","key":"8763_CR129","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.3390\/ijms26104907","volume":"26","author":"C Vargas","year":"2025","unstructured":"Vargas C, Aguirre-Ducler A, Cereceda K, Quijada S, Escobar-G\u00f3mez N, Castillo RL, et al. CD44 marks dormant tumor cells after HER2 inhibition in breast cancer cells. IJMS. 2025;26(10):4907. https:\/\/doi.org\/10.3390\/ijms26104907.","journal-title":"IJMS"},{"issue":"18","key":"8763_CR130","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1089\/ars.2019.7730","volume":"32","author":"D-H Kim","year":"2020","unstructured":"Kim D-H, Jang J-H, Kwon O-S, Cha H-J, Youn H-J, Chun K-S, et al. Nuclear factor erythroid-derived 2-like 2-induced reductive stress favors self-renewal of breast cancer stem-like cells via the FoxO3a-Bmi-1 Axis. Antioxid Redox Signal. 2020;32(18):1313\u201329. https:\/\/doi.org\/10.1089\/ars.2019.7730.","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"8763_CR131","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/cancers16050883","volume":"16","author":"NA Yousafzai","year":"2024","unstructured":"Yousafzai NA, El Khalki L, Wang W, Szpendyk J, Sossey-Alaoui K. Advances in 3D culture models to study Exosomes in triple-negative breast cancer. Cancers (Basel). 2024;16(5):883. https:\/\/doi.org\/10.3390\/cancers16050883.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"8763_CR132","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/biology14070875","volume":"14","author":"GD Marconi","year":"2025","unstructured":"Marconi GD, Mazzone A, Della Rocca Y, Trubiani O, Pizzicannella J, Diomede F. Three-dimensional culture system: a new frontier in cancer research, Drug discovery, and stem cell-based therapy. Biology. 2025;14(7):875. https:\/\/doi.org\/10.3390\/biology14070875.","journal-title":"Biology"},{"issue":"4","key":"8763_CR133","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1042\/EBC20220016","volume":"66","author":"M Katoh","year":"2022","unstructured":"Katoh M, Katoh M. WNT signaling and cancer stemness. Essays Biochem. 2022;66(4):319\u201331. https:\/\/doi.org\/10.1042\/EBC20220016.","journal-title":"Essays Biochem"},{"issue":"1","key":"8763_CR134","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymthe.2019.08.015","volume":"28","author":"Y Zou","year":"2020","unstructured":"Zou Y, Lin X, Bu J, Lin Z, Chen Y, Qiu Y, et al. Timeless-stimulated miR-5188-FOXO1\/\u03b2-catenin-c-Jun feedback loop promotes stemness via ubiquitination of \u03b2-catenin in breast cancer. Mol Ther. 2020;28(1):313\u201327. https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.015.","journal-title":"Mol Ther"},{"key":"8763_CR135","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biocel.2017.06.007","volume":"89","author":"S Siddharth","year":"2017","unstructured":"Siddharth S, Goutam K, Das S, Nayak A, Nayak D, Sethy C, et al. Nectin-4 is a breast cancer stem cell marker that induces WNT\/\u03b2-catenin signaling via Pi3k\/Akt axis. The Int J Biochem Cell Biol. 2017;89:85\u201394. https:\/\/doi.org\/10.1016\/j.biocel.2017.06.007.","journal-title":"The Int J Biochem Cell Biol"},{"issue":"1","key":"8763_CR136","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-016-0570-y","volume":"16","author":"A Al-Dhfyan","year":"2017","unstructured":"Al-Dhfyan A, Alhoshani A, Korashy H. Aryl hydrocarbon receptor\/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and \u03b2-catenin and akt activation. Mol Cancer. 2017;16(1):16. https:\/\/doi.org\/10.1186\/s12943-016-0570-y.","journal-title":"Mol Cancer"},{"issue":"1","key":"8763_CR137","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12885-016-2377-z","volume":"16","author":"S Gangadhara","year":"2016","unstructured":"Gangadhara S, Smith C, Barrett-Lee P, Hiscox S. 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response. BMC Cancer. 2016;16(1):345. https:\/\/doi.org\/10.1186\/s12885-016-2377-z.","journal-title":"BMC Cancer"},{"issue":"10","key":"8763_CR138","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3390\/cells9102204","volume":"9","author":"M BeLow","year":"2020","unstructured":"BeLow M, Osipo C. Notch signaling in breast cancer: a role in drug resistance. Cells. 2020;9(10):2204. https:\/\/doi.org\/10.3390\/cells9102204.","journal-title":"Cells"},{"issue":"1","key":"8763_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2415489","volume":"2018","author":"EN Kontomanolis","year":"2018","unstructured":"Kontomanolis EN, Kalagasidou S, Pouliliou S, Anthoulaki X, Georgiou N, Papamanolis V, et al. The notch pathway in breast cancer progression. ScientificWorldjournal. 2018;2018(1):1\u201311. https:\/\/doi.org\/10.1155\/2018\/2415489.","journal-title":"ScientificWorldjournal"},{"issue":"5","key":"8763_CR140","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/pharmaceutics17050572","volume":"17","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yang Y, Qi X. Combination therapy for overcoming multidrug resistance in breast cancer through hedgehog signaling pathway regulation. Pharmaceutics. 2025;17(5):572. https:\/\/doi.org\/10.3390\/pharmaceutics17050572.","journal-title":"Pharmaceutics"},{"issue":"9","key":"8763_CR141","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1042\/CS20140592","volume":"129","author":"M He","year":"2015","unstructured":"He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W, et al. The hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. Clin Sci (Lond, Engl: 1979). 2015;129(9):809\u201322. https:\/\/doi.org\/10.1042\/CS20140592.","journal-title":"Clin Sci (Lond, Engl: 1979)"},{"issue":"4","key":"8763_CR142","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cells8040375","volume":"8","author":"NA Riobo-Del Galdo","year":"2019","unstructured":"Riobo-Del Galdo NA, \u00c1 \u00c1, Wertheimer EV. Role of hedgehog signaling in breast cancer: pathogenesis and therapeutics. Cells. 2019;8(4):375. https:\/\/doi.org\/10.3390\/cells8040375.","journal-title":"Cells"},{"key":"8763_CR143","doi-asserted-by":"publisher","unstructured":"Madsen RR, Erickson EC, Rueda OM, Robin X, Caldas C, Toker A, et al. Positive correlation between transcriptomic stemness and PI3K\/AKT\/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotype. PLoS Genet. 2021;17(11):e1009876. https:\/\/doi.org\/10.1371\/journal.pgen.1009876.","DOI":"10.1371\/journal.pgen.1009876"},{"issue":"1","key":"8763_CR144","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Sig Transduct Target Ther. 2020;5(1):5. https:\/\/doi.org\/10.1038\/s41392-020-0110-5.","journal-title":"Sig Transduct Target Ther"},{"key":"8763_CR145","doi-asserted-by":"publisher","unstructured":"Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, et al. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN. PLoS One. 2012;7(6):e39520. https:\/\/doi.org\/10.1371\/journal.pone.0039520.","DOI":"10.1371\/journal.pone.0039520"},{"key":"8763_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9258396","volume":"2020","author":"MA Ortega","year":"2020","unstructured":"Ortega MA, Fraile-Mart\u00ednez O, As\u00fansolo \u00c1, Buj\u00e1n J, Garc\u00eda-Honduvilla N, Coca S. Signal transduction pathways in breast cancer: the important role of PI3K\/Akt\/mTOR. J Oncol. 2020;2020:1\u201311. https:\/\/doi.org\/10.1155\/2020\/9258396.","journal-title":"J Oncol"},{"issue":"6","key":"8763_CR147","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.7150\/ijbs.104850","volume":"21","author":"T Kang","year":"2025","unstructured":"Kang T, Wang Y, Jiang Y, Chen S, Lin N, Guo M, et al. The SGK3\/GSK3\u03b2\/\u03b2-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy. Int J Biol Sci. 2025;21(6):2462\u201375. https:\/\/doi.org\/10.7150\/ijbs.104850.","journal-title":"Int J Biol Sci"},{"key":"8763_CR148","doi-asserted-by":"publisher","unstructured":"Chen S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. iMeta. 2023;2(2):e107. https:\/\/doi.org\/10.1002\/imt2.107.","DOI":"10.1002\/imt2.107"},{"issue":"5","key":"8763_CR149","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ijc.31112","volume":"142","author":"J Yu","year":"2018","unstructured":"Yu J, Wang X, Lu Q, Wang J-G, Li L, Liao X, et al. Extracellular 5\u2032-nucleotidase (CD73) promotes human breast cancer cells growth through AKT\/GSK-3\u03b2\/\u03b2-catenin\/cyclinD1 signaling pathway. Intl J Cancer. 2018;142(5):959\u201367. https:\/\/doi.org\/10.1002\/ijc.31112.","journal-title":"Intl J Cancer"},{"issue":"1","key":"8763_CR150","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-022-02904-1","volume":"13","author":"F Ju","year":"2022","unstructured":"Ju F, Atyah MM, Horstmann N, Gul S, Vago R, Bruns CJ, et al. Characteristics of the cancer stem cell niche and therapeutic strategies. STEM Cell Res Ther. 2022;13(1):233. https:\/\/doi.org\/10.1186\/s13287-022-02904-1.","journal-title":"STEM Cell Res Ther"},{"issue":"9","key":"8763_CR151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/genes13091585","volume":"13","author":"Y Dekker","year":"2022","unstructured":"Dekker Y, D\u00e9v\u00e9dec SE, Danen E, Liu Q. Crosstalk between hypoxia and extracellular matrix in the tumor microenvironment in breast cancer. Genes. 2022;13(9):13. https:\/\/doi.org\/10.3390\/genes13091585.","journal-title":"Genes"},{"issue":"7","key":"8763_CR152","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1021\/acsabm.0c00448","volume":"3","author":"Y Li","year":"2020","unstructured":"Li Y, Randriantsilefisoa R, Chen J, Cu\u00e9llar-Camacho J, Liang W, Li W. Matrix stiffness regulates chemosensitivity, stemness characteristics, and autophagy in breast cancer cells. ACS Appl Bio Mater. 2020;3(7):4474\u201385. https:\/\/doi.org\/10.1021\/acsabm.0c00448.","journal-title":"ACS Appl Bio Mater"},{"issue":"3","key":"8763_CR153","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/path.6395","volume":"265","author":"X Lu","year":"2025","unstructured":"Lu X, Gou Z, Chen H, Li L, Chen F, Bao C, et al. Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer. The J Pathol. 2025;265(3):385\u201399. https:\/\/doi.org\/10.1002\/path.6395.","journal-title":"The J Pathol"},{"issue":"2","key":"8763_CR154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1096\/fj.202300203R","volume":"38","author":"S Tao","year":"2024","unstructured":"Tao S, Wang J, Li F, Shi B, Ren Q, Zhuang Y, et al. Extracellular vesicles released by hypoxia-induced tumor-associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery. Faseb J. 2024;38(2):38. https:\/\/doi.org\/10.1096\/fj.202300203R.","journal-title":"Faseb J"},{"issue":"21","key":"8763_CR155","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/adhm.202300164","volume":"12","author":"H Dhandapani","year":"2023","unstructured":"Dhandapani H, Siddiqui A, Karadkar S, Tayalia P. In vitro 3D spheroid Model preserves tumor microenvironment of hot and cold breast cancer subtypes. Adv Healthcare Mater. 2023;12(21):12. https:\/\/doi.org\/10.1002\/adhm.202300164.","journal-title":"Adv Healthcare Mater"},{"issue":"14","key":"8763_CR156","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms241411459","volume":"24","author":"M Watanabe","year":"2023","unstructured":"Watanabe M, Yano T, Sato T, Umetsu A, Higashide M, Furuhashi M, et al. mTOR inhibitors modulate the physical properties of 3D spheroids derived from H9c2 cells. IJMS. 2023;24(14):24. https:\/\/doi.org\/10.3390\/ijms241411459.","journal-title":"IJMS"},{"issue":"5","key":"8763_CR157","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s12015-021-10172-4","volume":"17","author":"Y-H Chan","year":"2021","unstructured":"Chan Y-H, Lee Y-C, Hung C-Y, Yang P-J, Lai P-C, Feng S-W. Three-dimensional spheroid culture enhances multipotent differentiation and stemness capacities of human dental pulp-derived mesenchymal stem cells by modulating MAPK and NF-kB signaling pathways. STEM Cell Rev Rep. 2021;17(5):1810\u201326. https:\/\/doi.org\/10.1007\/s12015-021-10172-4.","journal-title":"STEM Cell Rev Rep"},{"issue":"12","key":"8763_CR158","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmaceutics12121186","volume":"12","author":"B Pinto","year":"2020","unstructured":"Pinto B, Henriques A, Silva P, Bousbaa H. Three-dimensional spheroids as in vitro preclinical models for cancer research. Pharmaceutics. 2020;12(12):12. https:\/\/doi.org\/10.3390\/pharmaceutics12121186.","journal-title":"Pharmaceutics"},{"issue":"4","key":"8763_CR159","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1248\/bpb.b22-00772","volume":"46","author":"R Onodera","year":"2023","unstructured":"Onodera R, Jimma Y, Suzuki A, Habano W, Ozawa S, Terashima J. The regulation pathway of VEGF gene expression is different between 2D cells and 3D spheroids in human lung cancer cells. Biol Pharm Bull. 2023;46(4):608\u201313. https:\/\/doi.org\/10.1248\/bpb.b22-00772.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"8763_CR160","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.slasd.2021.10.008","volume":"27","author":"D Close","year":"2022","unstructured":"Close D, Johnston P. Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines. SLAS discovery: advancing life sciences R & D. 2021. SLAS Discov. 2022;27(1):39\u201354. https:\/\/doi.org\/10.1016\/j.slasd.2021.10.008.","journal-title":"SLAS Discov"},{"issue":"1","key":"8763_CR161","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12929-024-00997-9","volume":"31","author":"D Rodrigues","year":"2024","unstructured":"Rodrigues D, Reis R, Pirraco R. Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool. J Biomed Sci. 2024;31(1):31. https:\/\/doi.org\/10.1186\/s12929-024-00997-9.","journal-title":"J Biomed Sci"},{"key":"8763_CR162","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","volume":"163","author":"S Nath","year":"2016","unstructured":"Nath S, Devi G. Three-dimensional culture systems in cancer research: focus on tumor spheroid model. Pharmacol Ther. 2016;163:94\u2013108. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.03.013.","journal-title":"Pharmacol Ther"},{"key":"8763_CR163","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1242\/jcs.188102","volume":"130","author":"A Riedl","year":"2016","unstructured":"Riedl A, Schlederer M, Pudelko K, Stadler M, Walter S, Unterleuthner D, et al. Comparison of cancer cells cultured in 2D vs 3D reveals differences in AKT\/mTOR\/S6-kinase signaling and drug response. J Cell Sci. 2016;130:203\u201318. https:\/\/doi.org\/10.1242\/jcs.188102.","journal-title":"J Cell Sci"},{"issue":"1","key":"8763_CR164","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41598-017-10699-y","volume":"7","author":"H Shoval","year":"2017","unstructured":"Shoval H, Karsch-Bluman A, Brill-Karniely Y, Stern T, Zamir G, Hubert A, et al. Tumor cells and their crosstalk with endothelial cells in 3D spheroids. Sci Rep. 2017;7(1):7. https:\/\/doi.org\/10.1038\/s41598-017-10699-y.","journal-title":"Sci Rep"},{"issue":"13","key":"8763_CR165","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/advs.202410659","volume":"12","author":"J Ro","year":"2025","unstructured":"Ro J, Kim J, Park J, Choi Y, Cho Y. ODSEI Chip: an open 3D microfluidic platform for studying tumor spheroid-endothelial interactions. Adv Sci (Weinh)Adv Sci. 2025;12(13):12. https:\/\/doi.org\/10.1002\/advs.202410659.","journal-title":"Adv Sci (Weinh)Adv Sci"},{"issue":"7","key":"8763_CR166","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1039\/D1LC01177D","volume":"22","author":"D Rodoplu","year":"2022","unstructured":"Rodoplu D, Matahum J, Hsu C-H. A microfluidic hanging drop-based spheroid co-culture platform for probing tumor angiogenesis. Lab Chip. 2022;22(7):1275\u201385. https:\/\/doi.org\/10.1039\/D1LC01177D.","journal-title":"Lab Chip"},{"issue":"1","key":"8763_CR167","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biomedicines12010087","volume":"12","author":"A Romanzi","year":"2023","unstructured":"Romanzi A, Milosa F, Marcelli G, Critelli R, Lasagni S, Gigante I, et al. Angiopoietin-2 and the vascular endothelial growth factor promote migration and invasion in hepatocellular carcinoma- and intrahepatic Cholangiocarcinoma-derived spheroids. Biomedicines. 2023;12(1):12. https:\/\/doi.org\/10.3390\/biomedicines12010087.","journal-title":"Biomedicines"},{"issue":"1","key":"8763_CR168","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41420-018-0026-9","volume":"4","author":"S Wang","year":"2018","unstructured":"Wang S, Yan Y, Cheng Z, Hu Y, Liu T. Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-\u03b1\/NF-\u03baB and PI3K\/AKT signaling pathway. Cell Death Discov. 2018;4(1):4. https:\/\/doi.org\/10.1038\/s41420-018-0026-9.","journal-title":"Cell Death Discov"},{"key":"8763_CR169","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fonc.2022.898583","volume":"12","author":"C Wei","year":"2022","unstructured":"Wei C, Khan MA, Du J, Cheng J, Tania M, Leung E, et al. Cordycepin inhibits triple-negative breast cancer cell migration and invasion by regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1. Front Oncol. 2022;12:12. https:\/\/doi.org\/10.3389\/fonc.2022.898583.","journal-title":"Front Oncol"},{"issue":"2","key":"8763_CR170","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/bioengineering12020147","volume":"12","author":"M Szostakowska-Rodzo\u015b","year":"2025","unstructured":"Szostakowska-Rodzo\u015b M, Chmielarczyk M, Zacharska W, Fabisiewicz A, Kurzyk A, My\u015bliwy I, et al. Plasticity of expression of stem cell and EMT markers in breast cancer cells in 2D and 3D culture depend on the spatial parameters of cell Growth; mathematical modeling of mechanical stress in cell culture in relation to ECM stiffness. Bioengineering. 2025;12(2):147. https:\/\/doi.org\/10.3390\/bioengineering12020147.","journal-title":"Bioengineering"},{"issue":"3","key":"8763_CR171","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/ol.2022.13435","volume":"24","author":"P Rawal","year":"2022","unstructured":"Rawal P, Tripathi D, Nain V, Kaur S. VEGF\u2011mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. Oncol Lett. 2022;24(3):24. https:\/\/doi.org\/10.3892\/ol.2022.13435.","journal-title":"Oncol Lett"},{"issue":"4","key":"8763_CR172","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1088\/1758-5090\/aadbde","volume":"10","author":"Y Pang","year":"2018","unstructured":"Pang Y, Mao S, Yao R, He J, Zhou Z, Feng L, et al. TGF- \u03b2 induced epithelial\u2013mesenchymal transition in an advanced cervical tumor model by 3D printing. Biofabrication. 2018;10(4):10. https:\/\/doi.org\/10.1088\/1758-5090\/aadbde.","journal-title":"Biofabrication"},{"issue":"4","key":"8763_CR173","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/2211068216652846","volume":"22","author":"S Kessel","year":"2017","unstructured":"Kessel S, Cribbes S, D\u00e9ry O, Kuksin D, Sincoff E, Qiu J, et al. High-throughput 3D tumor spheroid screening method for cancer drug discovery using celigo image cytometry. SLAS Technol. 2017;22(4):454\u201365. https:\/\/doi.org\/10.1177\/2211068216652846.","journal-title":"SLAS Technol"},{"key":"8763_CR174","doi-asserted-by":"publisher","first-page":"117804","DOI":"10.1016\/j.biopha.2024.117804","volume":"183","author":"M \u015awierczewska","year":"2025","unstructured":"\u015awierczewska M, Nowacka M, Stasiak P, I\u017cycki D, Sterzy\u0144ska K, P\u0142\u00f3ciennik A, et al. Doxorubicin and topotecan resistance in ovarian cancer: gene expression and microenvironment analysis in 2D and 3D models. Biomed Pharmacother. 2025;183:117804. https:\/\/doi.org\/10.1016\/j.biopha.2024.117804.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8763_CR175","doi-asserted-by":"publisher","first-page":"35632","DOI":"10.1038\/s41598-025-19557-8","volume":"15","author":"DA Cristaldi","year":"2025","unstructured":"Cristaldi DA, Bedeschi M, Cavallaro G, Sargenti A, Pasqua S, Bonetti S, et al. Redefine tumor spheroids heterogeneity via PCA-coupled biophysical characterization. Sci Rep. 2025;15(1):35632. https:\/\/doi.org\/10.1038\/s41598-025-19557-8.","journal-title":"Sci Rep"},{"issue":"1","key":"8763_CR176","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41598-025-85445-w","volume":"15","author":"X Li","year":"2025","unstructured":"Li X, Zhang H, Dong J, Wang J. Tyrosine phosphatase SHP2 accelerated ovarian cancer via modulating integrin\/ E-Cadherin\/ ZEB1 induced EMT. Sci Rep. 2025;15(1):15. https:\/\/doi.org\/10.1038\/s41598-025-85445-w.","journal-title":"Sci Rep"},{"key":"8763_CR177","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.fct.2018.12.009","volume":"124","author":"Y Hseu","year":"2019","unstructured":"Hseu Y, Lin Y-C, Rajendran P, Thigarajan V, Mathew D, Lin K-Y, et al. Antrodia salmonea suppresses invasion and metastasis in triple-negative breast cancer cells by reversing EMT through the NF-\u03baB and Wnt\/\u03b2-catenin signaling pathway. Food Chem Toxicol: Int J Published Br Ind Biol Res Assoc. 2019;124:219\u201330. https:\/\/doi.org\/10.1016\/j.fct.2018.12.009.","journal-title":"Food Chem Toxicol: Int J Published Br Ind Biol Res Assoc"},{"issue":"6","key":"8763_CR178","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cells10061484","volume":"10","author":"A S\u0142awi\u0144ska-Brych","year":"2021","unstructured":"S\u0142awi\u0144ska-Brych A, Mizerska-Kowalska M, Kr\u00f3l S, Stepulak A, Zdzisi\u0144ska B. Xanthohumol impairs the PMA-Driven invasive behaviour of lung cancer cell line A549 and exerts anti-EMT action. Cells. 2021;10(6):10. https:\/\/doi.org\/10.3390\/cells10061484.","journal-title":"Cells"},{"issue":"2\u20133","key":"8763_CR179","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s44164-024-00074-3","volume":"3","author":"SN Bess","year":"2024","unstructured":"Bess SN, Smart GK, Igoe MJ, Muldoon TJ. Scaffold-free development of multicellular tumor spheroids with spatial characterization of structure and metabolic radial profiles. Vitro Model. 2024;3(2\u20133):91\u2013108. https:\/\/doi.org\/10.1007\/s44164-024-00074-3.","journal-title":"Vitro Model"},{"issue":"4","key":"8763_CR180","doi-asserted-by":"publisher","first-page":"041501","DOI":"10.1063\/5.0225807","volume":"8","author":"KC Liu","year":"2024","unstructured":"Liu KC, Chen YC, Hsieh CF, Wang MH, Zhong MX, Cheng NC. Scaffold-free 3D culture systems for stem cell-based tissue regeneration. APL Bioeng. 2024;8(4):041501. https:\/\/doi.org\/10.1063\/5.0225807.","journal-title":"APL Bioeng"},{"issue":"4","key":"8763_CR181","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1021\/acsomega.2c06052","volume":"8","author":"A Tevlek","year":"2023","unstructured":"Tevlek A, Kecili S, Ozcelik OS, Kulah H, Tekin HC. Spheroid engineering in microfluidic devices. ACS Omega. 2023;8(4):3630\u201349. https:\/\/doi.org\/10.1021\/acsomega.2c06052.","journal-title":"ACS Omega"},{"issue":"22","key":"8763_CR182","doi-asserted-by":"publisher","first-page":"12200","DOI":"10.3390\/ijms222212200","volume":"22","author":"O Habanjar","year":"2021","unstructured":"Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture Systems: tumor application, advantages, and disadvantages. IJMS. 2021;22(22):12200. https:\/\/doi.org\/10.3390\/ijms222212200.","journal-title":"IJMS"},{"key":"8763_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.archoralbio.2018.02.008","volume":"91","author":"S Zhang","year":"2018","unstructured":"Zhang S, Buttler-Buecher P, Denecke B, Arana-Chavez VE, Apel C. A comprehensive analysis of human dental pulp cell spheroids in a three-dimensional pellet culture system. Arch Oral Biol. 2018;91:1\u20138. https:\/\/doi.org\/10.1016\/j.archoralbio.2018.02.008.","journal-title":"Arch Oral Biol"},{"issue":"3\u20134","key":"8763_CR184","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10911-016-9359-2","volume":"21","author":"K Froehlich","year":"2016","unstructured":"Froehlich K, Haeger J-D, Heger J, Pastuschek J, Photini SM, Yan Y, et al. Generation of multicellular breast cancer tumor spheroids: comparison of different protocols. J Mammary Gland Biol Neoplasia. 2016;21(3\u20134):89\u201398. https:\/\/doi.org\/10.1007\/s10911-016-9359-2.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"13","key":"8763_CR185","doi-asserted-by":"publisher","first-page":"16948","DOI":"10.18632\/oncotarget.7659","volume":"7","author":"S Raghavan","year":"2016","unstructured":"Raghavan S, Mehta P, Horst EN, Ward MR, Rowley KR, Mehta G. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity. Oncotarget. 2016;7(13):16948\u201361. https:\/\/doi.org\/10.18632\/oncotarget.7659.","journal-title":"Oncotarget"},{"issue":"8","key":"8763_CR186","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/toxics10080415","volume":"10","author":"F Malh\u00e3o","year":"2022","unstructured":"Malh\u00e3o F, Macedo AC, Ramos AA, Rocha RE. Morphometrical, morphological, and immunocytochemical characterization of a tool for cytotoxicity research: 3D cultures of breast cell lines grown in ultra-low attachment plates. Toxics. 2022;10(8):415. https:\/\/doi.org\/10.3390\/toxics10080415.","journal-title":"Toxics"},{"issue":"14","key":"8763_CR187","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1096\/fj.07-8710com","volume":"21","author":"DM Dean","year":"2007","unstructured":"Dean DM, Napolitano AP, Youssef J, Morgan JR. Rods, tori, and honeycombs: the directed self-assembly of microtissues with prescribed microscale geometries. Faseb J. 2007;21(14):4005\u201312. https:\/\/doi.org\/10.1096\/fj.07-8710com.","journal-title":"Faseb J"},{"issue":"8","key":"8763_CR188","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1089\/ten.2006.0190","volume":"13","author":"AP Napolitano","year":"2007","unstructured":"Napolitano AP, Chai P, Dean DM, Morgan JR. Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng. 2007;13(8):2087\u201394. https:\/\/doi.org\/10.1089\/ten.2006.0190.","journal-title":"Tissue Eng"},{"key":"8763_CR189","doi-asserted-by":"publisher","unstructured":"Ohori-Morita Y, Ashry A, Niibe K, Egusa H. Current perspectives on the dynamic culture of mesenchymal stromal\/stem cell spheroids. STEM Cells Transl Med. 2025;14(3). https:\/\/doi.org\/10.1093\/stcltm\/szae093.","DOI":"10.1093\/stcltm\/szae093"},{"issue":"3","key":"8763_CR190","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00441-005-0148-2","volume":"324","author":"RZ Lin","year":"2006","unstructured":"Lin RZ, Chou LF, Chien C-CM, Chang HY. Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and \u03b21-integrin. Cell Tissue Res. 2006;324(3):411\u201322. https:\/\/doi.org\/10.1007\/s00441-005-0148-2.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"8763_CR191","doi-asserted-by":"publisher","first-page":"021002","DOI":"10.1088\/1758-5090\/aa7484","volume":"9","author":"M Devarasetty","year":"2017","unstructured":"Devarasetty M, Wang E, Soker S, Skardal A. Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy. Biofabrication. 2017;9(2):021002. https:\/\/doi.org\/10.1088\/1758-5090\/aa7484.","journal-title":"Biofabrication"},{"issue":"10","key":"8763_CR192","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/nprot.2013.125","volume":"8","author":"WL Haisler","year":"2013","unstructured":"Haisler WL, Timm DM, Gage JA, Tseng H, Killian TC, Souza GR. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8(10):1940\u201349. https:\/\/doi.org\/10.1038\/nprot.2013.125.","journal-title":"Nat Protoc"},{"issue":"3","key":"8763_CR193","doi-asserted-by":"publisher","first-page":"034102","DOI":"10.1063\/1.5016433","volume":"12","author":"M Rogers","year":"2018","unstructured":"Rogers M, Sobolik T, Schaffer DK, Samson PC, Johnson AC, Owens P, et al. Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment. Biomicrofluidics. 2018;12(3):034102. https:\/\/doi.org\/10.1063\/1.5016433.","journal-title":"Biomicrofluidics"},{"issue":"10","key":"8763_CR194","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/cells14100732","volume":"14","author":"S Shah","year":"2025","unstructured":"Shah S, D\u2019Souza GGM. Modeling tumor microenvironment complexity in vitro: spheroids as physiologically relevant tumor models and strategies for their analysis. Cells. 2025;14(10):732. https:\/\/doi.org\/10.3390\/cells14100732.","journal-title":"Cells"},{"issue":"16","key":"8763_CR195","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1016\/j.biomaterials.2013.02.045","volume":"34","author":"Z Xu","year":"2013","unstructured":"Xu Z, Gao Y, Hao Y, Li E, Wang Y, Zhang J, et al. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials. 2013;34(16):4109\u201317. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.045.","journal-title":"Biomaterials"},{"issue":"6","key":"8763_CR196","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.biomaterials.2011.11.049","volume":"33","author":"NC Cheng","year":"2012","unstructured":"Cheng NC, Wang S, Young TH. The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. Biomaterials. 2012;33(6):1748\u201358. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.11.049.","journal-title":"Biomaterials"},{"issue":"5","key":"8763_CR197","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/btpr.2497","volume":"33","author":"MP Carvalho","year":"2017","unstructured":"Carvalho MP, Costa EC, Correia IJ. Assembly of breast cancer heterotypic spheroids on hyaluronic acid coated surfaces. Biotechnol Prog. 2017;33(5):1346\u201357. https:\/\/doi.org\/10.1002\/btpr.2497.","journal-title":"Biotechnol Prog"},{"key":"8763_CR198","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.biomaterials.2018.02.049","volume":"165","author":"YB Lee","year":"2018","unstructured":"Lee YB, Kim EM, Byun H, Chang HK, Jeong K, Aman ZM, et al. Engineering spheroids potentiating cell-cell and cell-ECM interactions by self-assembly of stem cell microlayer. Biomaterials. 2018;165:105\u201320. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.02.049.","journal-title":"Biomaterials"},{"issue":"13","key":"8763_CR199","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties. Cancer Res. 2005;65(13):5506\u201311. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0626.","journal-title":"Cancer Res"},{"key":"8763_CR200","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bioactmat.2025.09.021","volume":"55","author":"C Zhang","year":"2026","unstructured":"Zhang C, Shen Y, Huang M, Wang G, Miao Q, Shi H, et al. Dynamic hydrogel mechanics in organoid engineering: from matrix design to translational paradigms. Bioact Mater. 2026;55:144\u201370. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.09.021.","journal-title":"Bioact Mater"},{"key":"8763_CR201","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.actbio.2022.09.052","volume":"165","author":"N Di Caprio","year":"2023","unstructured":"Di Caprio N, Burdick JA. Engineered biomaterials to guide spheroid formation, function, and fabrication into 3D tissue constructs. Acta Biomater. 2023;165:4\u201318. https:\/\/doi.org\/10.1016\/j.actbio.2022.09.052.","journal-title":"Acta Biomater"},{"key":"8763_CR202","doi-asserted-by":"publisher","first-page":"1150764","DOI":"10.3389\/fbioe.2023.1150764","volume":"11","author":"J Mason","year":"2023","unstructured":"Mason J, \u00d6hlund D. Key aspects for conception and construction of co-culture models of tumor-stroma interactions. Front Bioeng Biotechnol. 2023;11:1150764. https:\/\/doi.org\/10.3389\/fbioe.2023.1150764.","journal-title":"Front Bioeng Biotechnol"},{"issue":"22","key":"8763_CR203","doi-asserted-by":"publisher","first-page":"2101176","DOI":"10.1002\/advs.202101176","volume":"8","author":"P Chen","year":"2021","unstructured":"Chen P, Zhang X, Ding R, Yang L, Lyu X, Zeng J, et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer. Adv Sci (Weinh)Adv Sci. 2021;8(22):2101176. https:\/\/doi.org\/10.1002\/advs.202101176.","journal-title":"Adv Sci (Weinh)Adv Sci"},{"key":"8763_CR204","doi-asserted-by":"publisher","first-page":"111128","DOI":"10.1016\/j.msec.2020.111128","volume":"115","author":"G Kim","year":"2020","unstructured":"Kim G, Jung Y, Cho K, Lee HJ, Koh WG. Thermoresponsive poly(N-isopropylacrylamide) hydrogel substrates micropatterned with poly(ethylene glycol) hydrogel for adipose mesenchymal stem cell spheroid formation and retrieval. Mater Sci Eng: C. 2020;115:111128. https:\/\/doi.org\/10.1016\/j.msec.2020.111128.","journal-title":"Mater Sci Eng: C"},{"key":"8763_CR205","doi-asserted-by":"publisher","unstructured":"Campuzano S, Pelling AE. Scaffolds for 3D cell culture and cellular agriculture applications derived from non-animal sources. Front Sustain Food Syst. 2019;3:- 2019. https:\/\/doi.org\/10.3389\/fsufs.2019.00038.","DOI":"10.3389\/fsufs.2019.00038"},{"issue":"26","key":"8763_CR206","doi-asserted-by":"publisher","first-page":"1808110","DOI":"10.1002\/adma.201808110","volume":"31","author":"M Hippler","year":"2019","unstructured":"Hippler M, Lemma ED, Bertels S, Blasco E, Barner-Kowollik C, Wegener M, et al. 3D scaffolds to study basic cell biology. Adv Mater. 2019;31(26):1808110. https:\/\/doi.org\/10.1002\/adma.201808110.","journal-title":"Adv Mater"},{"issue":"1","key":"8763_CR207","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1038\/ncomms4935","volume":"5","author":"F Pati","year":"2014","unstructured":"Pati F, Jang J, Ha DH, Won Kim S, Rhie JW, Shim JH, et al. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun. 2014;5(1):3935. https:\/\/doi.org\/10.1038\/ncomms4935.","journal-title":"Nat Commun"},{"issue":"1","key":"8763_CR208","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/btm2.10124","volume":"4","author":"S Afewerki","year":"2019","unstructured":"Afewerki S, Sheikhi A, Kannan S, Ahadian S, Khademhosseini A. Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: towards natural therapeutics. Bioeng & Transla Med. 2019;4(1):96\u2013115. https:\/\/doi.org\/10.1002\/btm2.10124.","journal-title":"Bioeng & Transla Med"},{"issue":"28","key":"8763_CR209","doi-asserted-by":"publisher","first-page":"8164","DOI":"10.1016\/j.biomaterials.2014.04.090","volume":"35","author":"TJ Long","year":"2014","unstructured":"Long TJ, Sprenger CC, Plymate SR, Ratner BD. Prostate cancer xenografts engineered from 3D precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis and dormancy escape. Biomaterials. 2014;35(28):8164\u201374. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.090.","journal-title":"Biomaterials"},{"issue":"6","key":"8763_CR210","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ccr.2011.05.008","volume":"19","author":"MS Samuel","year":"2011","unstructured":"Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and \u03b2-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell. 2011;19(6):776\u201391. https:\/\/doi.org\/10.1016\/j.ccr.2011.05.008.","journal-title":"Cancer Cell"},{"issue":"38","key":"8763_CR211","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1016\/j.biomaterials.2013.09.034","volume":"34","author":"SJ Florczyk","year":"2013","unstructured":"Florczyk SJ, Wang K, Jana S, Wood DL, Sytsma SK, Sham J, et al. Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM. Biomaterials. 2013;34(38):10143\u201350. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.09.034.","journal-title":"Biomaterials"},{"key":"8763_CR212","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biomaterials.2015.12.016","volume":"81","author":"G Rijal","year":"2016","unstructured":"Rijal G, Li W. 3D scaffolds in breast cancer research. Biomaterials. 2016;81:135\u201356. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.12.016.","journal-title":"Biomaterials"},{"issue":"5","key":"8763_CR213","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/2472555217693191","volume":"22","author":"N Zhang","year":"2017","unstructured":"Zhang N, Milleret V, Thompson-Steckel G, Huang NP, V\u00f6r\u00f6s J, Simona BR, et al. Soft hydrogels featuring in-depth surface density gradients for the simple establishment of 3D tissue models for screening applications. SLAS discovery: advancing life sciences R & D. 2017. SLAS Discov. 2017;22(5):635\u201344. https:\/\/doi.org\/10.1177\/2472555217693191.","journal-title":"SLAS Discov"},{"issue":"2","key":"8763_CR214","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00253-014-6253-y","volume":"99","author":"F Ruedinger","year":"2015","unstructured":"Ruedinger F, Lavrentieva A, Blume C, Pepelanova I, Scheper T. Hydrogels for 3D mammalian cell culture: a starting guide for laboratory practice. Appl Microbiol Biotechnol. 2015;99(2):623\u201336. https:\/\/doi.org\/10.1007\/s00253-014-6253-y.","journal-title":"Appl Microbiol Biotechnol"},{"key":"8763_CR215","doi-asserted-by":"publisher","unstructured":"Girard YK, Wang C, Ravi S, Howell MC, Mallela J, Alibrahim M, et al. A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development. PLoS One. 2013;8(10):e75345. https:\/\/doi.org\/10.1371\/journal.pone.0075345.","DOI":"10.1371\/journal.pone.0075345"},{"issue":"8","key":"8763_CR216","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/D5BM00049A","volume":"13","author":"S Dupuy","year":"2025","unstructured":"Dupuy S, Salvador J, Morille M, No\u00ebl D, Belamie E. Control and interplay of scaffold\u2013biomolecule interactions applied to cartilage tissue engineering. Biomater Sci. 2025;13(8):1871\u2013900. https:\/\/doi.org\/10.1039\/D5BM00049A.","journal-title":"Biomater Sci"},{"key":"8763_CR217","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biomaterials.2016.10.052","volume":"115","author":"S Pradhan","year":"2017","unstructured":"Pradhan S, Clary JM, Seliktar D, Lipke EA. A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres. Biomaterials. 2017;115:141\u201354. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.10.052.","journal-title":"Biomaterials"},{"key":"8763_CR218","doi-asserted-by":"publisher","first-page":"733652","DOI":"10.3389\/fonc.2021.733652","volume":"11","author":"K Unnikrishnan","year":"2021","unstructured":"Unnikrishnan K, Thomas LV, Ram Kumar RM. Advancement of scaffold-based 3D cellular models in cancer tissue engineering: an update. Front Oncol. 2021;11:733652. https:\/\/doi.org\/10.3389\/fonc.2021.733652.","journal-title":"Front Oncol"},{"issue":"30","key":"8763_CR219","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1016\/j.biomaterials.2009.07.054","volume":"30","author":"LA Gurski","year":"2009","unstructured":"Gurski LA, Jha AK, Zhang C, Jia X, Farach-Carson MC. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials. 2009;30(30):6076\u201385. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.07.054.","journal-title":"Biomaterials"},{"issue":"1","key":"8763_CR220","doi-asserted-by":"publisher","first-page":"19560","DOI":"10.1038\/s41598-024-69047-6","volume":"14","author":"G Demirel","year":"2024","unstructured":"Demirel G, Cak\u0131l YD, Koltuk G, Aktas RG, Cal\u0131skan M. The use of hyaluronic acid in a 3D biomimetic scaffold supports spheroid formation and the culture of cancer stem cells. Sci Rep. 2024;14(1):19560. https:\/\/doi.org\/10.1038\/s41598-024-69047-6.","journal-title":"Sci Rep"},{"issue":"1","key":"8763_CR221","doi-asserted-by":"publisher","first-page":"22294","DOI":"10.1038\/s41598-020-79448-y","volume":"10","author":"G Bassi","year":"2020","unstructured":"Bassi G, Panseri S, Dozio SM, Sandri M, Campodoni E, Dapporto M, et al. Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche. Sci Rep. 2020;10(1):22294. https:\/\/doi.org\/10.1038\/s41598-020-79448-y.","journal-title":"Sci Rep"},{"issue":"12","key":"8763_CR222","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.4155\/bio.12.133","volume":"4","author":"X() Li","year":"2012","unstructured":"Li X(), Valadez AV, Zuo P, Nie Z. Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis. 2012;4(12):1509\u201325. https:\/\/doi.org\/10.4155\/bio.12.133.","journal-title":"Bioanalysis"},{"issue":"1","key":"8763_CR223","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-017-0654-6","volume":"37","author":"J-H Lee","year":"2018","unstructured":"Lee J-H, Kim S-K, Khawar IA, Jeong S-Y, Chung S, Kuh H-J. Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance. J Exp Clin Cancer Res. 2018;37(1):4. https:\/\/doi.org\/10.1186\/s13046-017-0654-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"14","key":"8763_CR224","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1039\/C9AN00612E","volume":"144","author":"Y Chen","year":"2019","unstructured":"Chen Y, Sun W, Kang L, Wang Y, Zhang M, Zhang H, et al. Microfluidic co-culture of liver tumor spheroids with stellate cells for the investigation of drug resistance and intercellular interactions. Analyst (Lond). 2019;144(14):4233\u201340. https:\/\/doi.org\/10.1039\/C9AN00612E.","journal-title":"Analyst (Lond)"},{"key":"8763_CR225","doi-asserted-by":"publisher","unstructured":"Jeong SY, Lee JH, Shin Y, Chung S, Kuh HJ. Co-culture of tumor spheroids and Fibroblasts in a collagen matrix-incorporated Microfluidic Chip mimics reciprocal activation in solid tumor microenvironment. PLoS One. 2016;11(7):e0159013. https:\/\/doi.org\/10.1371\/journal.pone.0159013.","DOI":"10.1371\/journal.pone.0159013"},{"issue":"1","key":"8763_CR226","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11033-026-11451-4","volume":"53","author":"SM Mohamedahmed","year":"2026","unstructured":"Mohamedahmed SM, Kamarudin MNA, Ramdas P, Sundralingam U, Radhakrishnan AK. Optimising the method to develop spheroids from MDA-MB-468 human triple negative breast cancer cells. Mol Biol Rep. 2026;53(1):322. https:\/\/doi.org\/10.1007\/s11033-026-11451-4.","journal-title":"Mol Biol Rep"},{"issue":"9\u201310","key":"8763_CR227","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/biot.200700228","volume":"3","author":"RZ Lin","year":"2008","unstructured":"Lin RZ, Chang HY. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J. 2008;3(9\u201310):1172\u201384. https:\/\/doi.org\/10.1002\/biot.200700228.","journal-title":"Biotechnol J"},{"issue":"12","key":"8763_CR228","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1002\/bit.27941","volume":"118","author":"M Anil-Inevi","year":"2021","unstructured":"Anil-Inevi M, Delikoyun K, Mese G, Tekin HC, Ozcivici E. Magnetic levitation assisted biofabrication, culture, and manipulation of 3D cellular structures using a ring magnet based setup. Biotech & Bioeng. 2021;118(12):4771\u201385. https:\/\/doi.org\/10.1002\/bit.27941.","journal-title":"Biotech & Bioeng"},{"issue":"22","key":"8763_CR229","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.3390\/polym13223957","volume":"13","author":"C Li","year":"2021","unstructured":"Li C, Zhang M, Liu SY, Zhang FS, Wan T, Ding ZT, et al. Chitin nerve conduits with three-dimensional spheroids of mesenchymal stem cells from SD rats promote peripheral nerve regeneration. Polymers. 2021;13(22):3957. https:\/\/doi.org\/10.3390\/polym13223957.","journal-title":"Polymers"},{"issue":"7","key":"8763_CR230","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/adt.2015.655","volume":"13","author":"O Sirenko","year":"2015","unstructured":"Sirenko O, Mitlo T, Hesley J, Luke S, Owens W, Cromwell EF. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures. Assay Drug Dev Technol. 2015;13(7):402\u201314. https:\/\/doi.org\/10.1089\/adt.2015.655.","journal-title":"Assay Drug Dev Technol"},{"issue":"1","key":"8763_CR231","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1741-7007-10-29","volume":"10","author":"M Vinci","year":"2012","unstructured":"Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, et al. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol. 2012;10(1):29. https:\/\/doi.org\/10.1186\/1741-7007-10-29.","journal-title":"BMC Biol"},{"issue":"7","key":"8763_CR232","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s12010-010-8975-3","volume":"162","author":"J Xiao","year":"2010","unstructured":"Xiao J, Zhang Y, Wang J, Yu W, Wang W, Ma X. Monitoring of cell viability and proliferation in hydrogel-encapsulated system by resazurin assay. Appl Biochem Biotechnol. 2010;162(7):1996\u20132007. https:\/\/doi.org\/10.1007\/s12010-010-8975-3.","journal-title":"Appl Biochem Biotechnol"},{"issue":"7","key":"8763_CR233","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/1087057107306839","volume":"12","author":"J Friedrich","year":"2007","unstructured":"Friedrich J, Eder W, Castaneda J, Doss M, Huber E, Ebner R, et al. A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay. SLAS Discov. 2007;12(7):925\u201337. https:\/\/doi.org\/10.1177\/1087057107306839.","journal-title":"SLAS Discov"},{"issue":"3","key":"8763_CR234","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ahe.12190","volume":"45","author":"C Gebhard","year":"2016","unstructured":"Gebhard C, Gabriel C, Walter I. Morphological and immunohistochemical characterization of canine osteosarcoma spheroid cell cultures. Anat Histol Embryol. 2016;45(3):219\u201330. https:\/\/doi.org\/10.1111\/ahe.12190.","journal-title":"Anat Histol Embryol"},{"issue":"8","key":"8763_CR235","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/cbin.11618","volume":"45","author":"W Metzger","year":"2021","unstructured":"Metzger W, R\u00f6sch B, Sossong D, Bubel M, Pohlemann T. Flow cytometric quantification of apoptotic and proliferating cells applying an improved method for dissociation of spheroids. Cell Biol Int. 2021;45(8):1633\u201343. https:\/\/doi.org\/10.1002\/cbin.11618.","journal-title":"Cell Biol Int"},{"issue":"1","key":"8763_CR236","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bit.26845","volume":"116","author":"A Nunes","year":"2019","unstructured":"Nunes A, Barros A, Costa E, Moreira A, Correia I. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotech & Bioeng. 2019;116(1):206\u201326. https:\/\/doi.org\/10.1002\/bit.26845.","journal-title":"Biotech & Bioeng"},{"key":"8763_CR237","doi-asserted-by":"publisher","first-page":"115152","DOI":"10.1016\/j.biopha.2023.115152","volume":"165","author":"M \u015awierczewska","year":"2023","unstructured":"\u015awierczewska M, Sterzy\u0144ska K, Ruci\u0144ski M, Andrzejewska M, Nowicki M, Januchowski R. The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids. Biomed Pharmacother. 2023;165:115152. https:\/\/doi.org\/10.1016\/j.biopha.2023.115152.","journal-title":"Biomed Pharmacother"},{"key":"8763_CR238","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","volume":"27","author":"W Li","year":"2016","unstructured":"Li W, Zhang H, Assaraf Y, Zhao K, Xu X, Xie J, et al. Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 2016. Drug Resist Updates. 2016;27:14\u201329. https:\/\/doi.org\/10.1016\/j.drup.2016.05.001.","journal-title":"Drug Resist Updates"},{"key":"8763_CR239","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphar.2021.648407","volume":"12","author":"H Xiao","year":"2021","unstructured":"Xiao H, Zheng Y, Ma TL, Tian L, Sun Q. Clinically-relevant ABC transporter for anti-cancer drug resistance. Front Pharmacol. 2021;12:12. https:\/\/doi.org\/10.3389\/fphar.2021.648407.","journal-title":"Front Pharmacol"},{"issue":"7","key":"8763_CR240","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"R Robey","year":"2018","unstructured":"Robey R, Pluchino K, Hall M, Fojo A, Bates S, Gottesman M. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18(7):452\u201364. https:\/\/doi.org\/10.1038\/s41568-018-0005-8.","journal-title":"Nat Rev Cancer"},{"key":"8763_CR241","doi-asserted-by":"crossref","unstructured":"Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell death & disease. 2020;11.","DOI":"10.1038\/s41419-020-02998-6"},{"key":"8763_CR242","doi-asserted-by":"publisher","first-page":"111055","DOI":"10.1016\/j.cbi.2024.111055","volume":"396","author":"M Tufail","year":"2024","unstructured":"Tufail M, Wan W, Jiang C, Li N. Targeting PI3K\/AKT\/mTOR signaling to overcome drug resistance in cancer. Chemico-Biol Interact. 2024;396:111055. https:\/\/doi.org\/10.1016\/j.cbi.2024.111055.","journal-title":"Chemico-Biol Interact"},{"key":"8763_CR243","doi-asserted-by":"crossref","unstructured":"Hong S, Song J. 3D Bioprinted Drug-resistant breast cancer spheroids for quantitative in situ evaluation of Drug resistance. Acta biomaterialia. 2021.","DOI":"10.1016\/j.actbio.2021.10.031"},{"key":"8763_CR244","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fonc.2022.856974","volume":"12","author":"T Saha","year":"2022","unstructured":"Saha T, Lukong K. Breast cancer stem-like cells in drug resistance: a review of mechanisms and novel therapeutic strategies to overcome drug resistance. Front Oncol. 2022;12:12. https:\/\/doi.org\/10.3389\/fonc.2022.856974.","journal-title":"Front Oncol"},{"key":"8763_CR245","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fphar.2020.599965","volume":"11","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Zhang M, Zhou F, Zhang L, Meng X. The breast cancer stem cells traits and drug resistance. Front Pharmacol. 2021;11:11. https:\/\/doi.org\/10.3389\/fphar.2020.599965.","journal-title":"Front Pharmacol"},{"issue":"1","key":"8763_CR246","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12935-021-01853-8","volume":"21","author":"S Han","year":"2021","unstructured":"Han S, Kwon S, Kim K. Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int. 2021;21(1):21. https:\/\/doi.org\/10.1186\/s12935-021-01853-8.","journal-title":"Cancer Cell Int"},{"key":"8763_CR247","doi-asserted-by":"publisher","first-page":"111815","DOI":"10.1016\/j.biopha.2021.111815","volume":"141","author":"A Urbaniak","year":"2021","unstructured":"Urbaniak A, Reed MR, Fil D, Moorjani A, Heflin S, Antoszczak M, et al. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models. Biomed Pharmacother. 2021;141:111815. https:\/\/doi.org\/10.1016\/j.biopha.2021.111815.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"8763_CR248","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41565-020-00793-0","volume":"16","author":"S Shen","year":"2021","unstructured":"Shen S, Xu X, Lin S, Zhang Y, Liu H, Zhang C, et al. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nat. Nanotechnol. 2021;16(1):104\u201313. https:\/\/doi.org\/10.1038\/s41565-020-00793-0.","journal-title":"Nat. Nanotechnol"},{"issue":"11","key":"8763_CR249","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1021\/acs.molpharmaceut.1c00220","volume":"18","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yu F, Dai S, Meng T, Zhu Y, Qiu G, et al. All-trans retinoic acid and doxorubicin delivery by folic acid modified polymeric micelles for the modulation of Pin1-mediated DOX-Induced breast cancer stemness and metastasis. Mol. Pharm. 2021;18(11):3966\u201378. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00220.","journal-title":"Mol. Pharm"},{"issue":"1","key":"8763_CR250","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13046-024-03014-x","volume":"43","author":"S Camorani","year":"2024","unstructured":"Camorani S, Caliendo A, Morrone E, Agnello L, Martini M, Cantile M, et al. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies. J Exp Clin Cancer Res. 2024;43(1):43. https:\/\/doi.org\/10.1186\/s13046-024-03014-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"8763_CR251","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22094673","volume":"22","author":"V Gote","year":"2021","unstructured":"Gote V, Nookala A, Bolla PK, Pal D. Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue. IJMS. 2021;22(9):22. https:\/\/doi.org\/10.3390\/ijms22094673.","journal-title":"IJMS"},{"key":"8763_CR252","doi-asserted-by":"publisher","first-page":"215754","DOI":"10.1016\/j.ccr.2024.215754","volume":"508","author":"H Abolhassani","year":"2024","unstructured":"Abolhassani H, Eskandari A, Poor AS, Zarrabi A, Khodadadi B, Karimifard S, et al. Nanobiotechnological approaches for breast cancer management: drug delivery systems and 3D in-vitro models. Coord Chem Rev. 2024;508:215754. https:\/\/doi.org\/10.1016\/j.ccr.2024.215754.","journal-title":"Coord Chem Rev"},{"issue":"1","key":"8763_CR253","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1088\/2516-1091\/ad9dcb","volume":"7","author":"NS Roy","year":"2025","unstructured":"Roy NS, Kumari M, Alam K, Bhattacharya A, Kaity S, Kaur K, et al. Development of bioengineered 3D patient derived breast cancer organoid model focusing dynamic fibroblast\u2013stem cell reciprocity. Prog Biomed Eng. 2025;7(1):7. https:\/\/doi.org\/10.1088\/2516-1091\/ad9dcb.","journal-title":"Prog Biomed Eng"},{"key":"8763_CR254","doi-asserted-by":"publisher","first-page":"106560","DOI":"10.1016\/j.ejps.2023.106560","volume":"190","author":"M Domingues","year":"2023","unstructured":"Domingues M, Pereira C, Sarmento B, Castro F. Mimicking 3D breast tumor-stromal interactions to screen novel cancer therapeutics. Eur J Pharm Sci: Off J Eur Fed Pharm Sci. 2023;190:106560. https:\/\/doi.org\/10.1016\/j.ejps.2023.106560.","journal-title":"Eur J Pharm Sci: Off J Eur Fed Pharm Sci"},{"issue":"7","key":"8763_CR255","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17071161","volume":"17","author":"S Mangani","year":"2025","unstructured":"Mangani S, Kremmydas S, Karamanos N. Mimicking the complexity of solid tumors: how spheroids could advance cancer preclinical transformative approaches. Cancers. 2025;17(7):17. https:\/\/doi.org\/10.3390\/cancers17071161.","journal-title":"Cancers"},{"issue":"6","key":"8763_CR256","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/adhm.201700980","volume":"7","author":"P Thakuri","year":"2018","unstructured":"Thakuri P, Liu C, Luker G, Tavana H. Biomaterials-based approaches to tumor spheroid and organoid modeling. Adv Healthcare Mater. 2018;7(6):7. https:\/\/doi.org\/10.1002\/adhm.201700980.","journal-title":"Adv Healthcare Mater"},{"key":"8763_CR257","doi-asserted-by":"publisher","unstructured":"Wu J, Cheng J, Zhu L, Gao Q, Lin H, Zeng Y, et al. CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicity. J Immunother Cancer. 2025;13(11):e012243. https:\/\/doi.org\/10.1136\/jitc-2025-012243.","DOI":"10.1136\/jitc-2025-012243"},{"key":"8763_CR258","doi-asserted-by":"publisher","unstructured":"Cheng J, Hu X, Dai Z, Zeng Y, Jin J, Mu W, et al. Targeting intracellular LMP2 with costimulatory signal\u2013armed antibody-like TCR T cells. JCI Insight. 2025;10(10):e178572. https:\/\/doi.org\/10.1172\/jci.insight.178572.","DOI":"10.1172\/jci.insight.178572"},{"issue":"12","key":"8763_CR259","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.4252\/wjsc.v11.i12.1065","volume":"11","author":"N Chaicharoenaudomrung","year":"2019","unstructured":"Chaicharoenaudomrung N, Kunhorm P, Noisa P. Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling. WJSC. 2019;11(12):1065\u201383. https:\/\/doi.org\/10.4252\/wjsc.v11.i12.1065.","journal-title":"WJSC"},{"issue":"1","key":"8763_CR260","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1038\/s41467-024-48010-z","volume":"15","author":"D Ascheid","year":"2024","unstructured":"Ascheid D, Baumann M, Pinnecker J, Friedrich M, Szi-Marton D, Medved C, et al. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy. Nat Commun. 2024;15(1):3599. https:\/\/doi.org\/10.1038\/s41467-024-48010-z.","journal-title":"Nat Commun"},{"issue":"1","key":"8763_CR261","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jmi.13169","volume":"291","author":"T Phillips","year":"2023","unstructured":"Phillips T, Caprettini V, Aggarwal N, Marcotti S, Tetley R, Mao Y, et al. A method for reproducible high-resolution imaging of 3D cancer cell spheroids. J Microscopy. 2023;291(1):30\u201342. https:\/\/doi.org\/10.1111\/jmi.13169.","journal-title":"J Microscopy"},{"issue":"1","key":"8763_CR262","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1088\/1758-5090\/ad8bf5","volume":"17","author":"T Hildebrand","year":"2025","unstructured":"Hildebrand T, Ma Q, Loca D, Rubenis K, Locs J, Nogueira LP, et al. Improved visualisation of ACP-engineered osteoblastic spheroids: a comparative study of contrast-enhanced micro-CT and traditional imaging techniques. Biofabrication. 2025;17(1):17. https:\/\/doi.org\/10.1088\/1758-5090\/ad8bf5.","journal-title":"Biofabrication"},{"issue":"3","key":"8763_CR263","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/2472630318756058","volume":"23","author":"E Leary","year":"2018","unstructured":"Leary E, Rhee C, Wilks B, Morgan J. Quantitative live-cell confocal imaging of 3D spheroids in a high-throughput format. SLAS Technol. 2018;23(3):231\u201342. https:\/\/doi.org\/10.1177\/2472630318756058.","journal-title":"SLAS Technol"},{"issue":"12","key":"8763_CR264","doi-asserted-by":"publisher","first-page":"18046","DOI":"10.1021\/acsami.4c22228","volume":"17","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Sanders H, Dragun V, Cole S, Smith B. Fluorescent molecular probe for imaging hypoxia in 2D cell culture Monolayers and 3D tumor spheroids: the cell membrane partition Model for predicting probe distribution in a spheroid. ACS Appl. Mater. Interface. 2025;17(12):18046\u201358. https:\/\/doi.org\/10.1021\/acsami.4c22228.","journal-title":"ACS Appl. Mater. Interface"},{"issue":"2","key":"8763_CR265","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12015-023-10655-6","volume":"20","author":"PE Mulaudzi","year":"2024","unstructured":"Mulaudzi PE, Abrahamse H, Crous A. Insights on three dimensional organoid studies for stem cell therapy in regenerative medicine. STEM Cell Rev Rep. 2024;20(2):509\u201323. https:\/\/doi.org\/10.1007\/s12015-023-10655-6.","journal-title":"STEM Cell Rev Rep"},{"issue":"13","key":"8763_CR266","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cancers15133350","volume":"15","author":"R Kerslake","year":"2023","unstructured":"Kerslake R, Belay B, Panfilov S, Hall M, Kyrou I, Randeva H, et al. Transcriptional landscape of 3D vs. 2D ovarian cancer cell models. Cancers. 2023;15(13):15. https:\/\/doi.org\/10.3390\/cancers15133350.","journal-title":"Cancers"},{"issue":"1","key":"8763_CR267","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cancers14010190","volume":"14","author":"MAG Barbosa","year":"2021","unstructured":"Barbosa MAG, Xavier CPR, Pereira RF, Petrikait\u0117 V, Vasconcelos MH. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers (Basel). 2021;14(1):190. https:\/\/doi.org\/10.3390\/cancers14010190.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"8763_CR268","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/adfm.202419912","volume":"35","author":"N Natesh","year":"2025","unstructured":"Natesh N, Varghese S. Advances and challenges in human 3D solid tumor models. Adv Funct Mater. 2025;35(20):35. https:\/\/doi.org\/10.1002\/adfm.202419912.","journal-title":"Adv Funct Mater"},{"key":"8763_CR269","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.addr.2021.04.018","volume":"174","author":"M Heinrich","year":"2021","unstructured":"Heinrich M, Mostafa A, Morton J, Hawinkels L, Prakash J. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Adv Drug Deliv Rev. 2021;174:265\u201393. https:\/\/doi.org\/10.1016\/j.addr.2021.04.018.","journal-title":"Adv Drug Deliv Rev"},{"key":"8763_CR270","doi-asserted-by":"crossref","unstructured":"Germain N, Dhayer M, Dekiouk S, Marchetti P. Current advances in 3D bioprinting for cancer modeling and personalized medicine. Int J Mol Sci. 2022;23.","DOI":"10.20944\/preprints202202.0303.v1"},{"issue":"1","key":"8763_CR271","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13287-024-03768-3","volume":"15","author":"T Xiang","year":"2024","unstructured":"Xiang T, Wang J, Li H. Current applications of intestinal organoids: a review. STEM Cell Res Ther. 2024;15(1):155. https:\/\/doi.org\/10.1186\/s13287-024-03768-3.","journal-title":"STEM Cell Res Ther"},{"issue":"8","key":"8763_CR272","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24087116","volume":"24","author":"E Fr\u00f6hlich","year":"2023","unstructured":"Fr\u00f6hlich E. The variety of 3D breast cancer models for the study of tumor physiology and drug screening. IJMS. 2023;24(8):24. https:\/\/doi.org\/10.3390\/ijms24087116.","journal-title":"IJMS"},{"issue":"9","key":"8763_CR273","doi-asserted-by":"publisher","first-page":"5552","DOI":"10.1021\/acsabm.0c00791","volume":"3","author":"Y Kang","year":"2020","unstructured":"Kang Y, Datta P, Shanmughapriya S, Ozbolat I. 3D bioprinting of tumor models for cancer research. ACS Appl Bio Mater. 2020;3(9):5552\u201373. https:\/\/doi.org\/10.1021\/acsabm.0c00791.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"8763_CR274","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/srep19103","volume":"6","author":"M Zanoni","year":"2016","unstructured":"Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R, et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6(1):6. https:\/\/doi.org\/10.1038\/srep19103.","journal-title":"Sci Rep"},{"issue":"2","key":"8763_CR275","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/advs.202304460","volume":"11","author":"H Sun","year":"2024","unstructured":"Sun H, Sun L, Ke X, Liu L, Li C, Jin B, et al. Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases. Adv Sci (Weinh)Adv Sci. 2024;11(2):11. https:\/\/doi.org\/10.1002\/advs.202304460.","journal-title":"Adv Sci (Weinh)Adv Sci"},{"issue":"12","key":"8763_CR276","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41568-022-00514-w","volume":"22","author":"L Neufeld","year":"2022","unstructured":"Neufeld L, Yeini E, Pozzi S, Satchi-Fainaro R. 3D bioprinted cancer models: from basic biology to drug development. Nat Rev Cancer. 2022;22(12):679\u201392. https:\/\/doi.org\/10.1038\/s41568-022-00514-w.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"8763_CR277","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","volume":"29","author":"S Ding","year":"2022","unstructured":"Ding S, Hsu C, Wang Z, Natesh N, Millen R, Negrete M, et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell STEM Cell. 2022;29(6):905\u201317.e6. https:\/\/doi.org\/10.1016\/j.stem.2022.04.006.","journal-title":"Cell STEM Cell"},{"issue":"9","key":"8763_CR278","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","volume":"24","author":"F Weeber","year":"2017","unstructured":"Weeber F, Ooft S, Dijkstra K, Voest E. Tumor organoids as a pre-clinical cancer Model for drug discovery. Cell Chem Biol. 2017;24(9):1092\u2013100. https:\/\/doi.org\/10.1016\/j.chembiol.2017.06.012.","journal-title":"Cell Chem Biol"},{"issue":"11","key":"8763_CR279","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/ijc.35386","volume":"156","author":"P Schwerd-Kleine","year":"2025","unstructured":"Schwerd-Kleine P, W\u00fcrth R, Cheytan T, Michel L, Thewes V, Gutjahr E, et al. Biopsy-derived organoids in personalised early breast cancer care: challenges of tumour purity and normal cell overgrowth cap their practical utility. Intl J Cancer. 2025;156(11):2200\u201309. https:\/\/doi.org\/10.1002\/ijc.35386.","journal-title":"Intl J Cancer"},{"issue":"4","key":"8763_CR280","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.tranon.2021.101015","volume":"14","author":"R Augustine","year":"2021","unstructured":"Augustine R, Kalva S, Ahmad R, Zahid AA, Hasan S, Nayeem A, et al. 3D bioprinted cancer models: revolutionizing personalized cancer therapy. Transl Oncol. 2021;14(4):14. https:\/\/doi.org\/10.1016\/j.tranon.2021.101015.","journal-title":"Transl Oncol"},{"issue":"3","key":"8763_CR281","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1088\/1758-5090\/ad51a6","volume":"16","author":"R Dai","year":"2024","unstructured":"Dai R, Chen W, Chen Y, Jin J, Zhang S, Zhang C, et al. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation. Biofabrication. 2024;16(3):16. https:\/\/doi.org\/10.1088\/1758-5090\/ad51a6.","journal-title":"Biofabrication"},{"issue":"20","key":"8763_CR282","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/advs.202407871","volume":"12","author":"J Han","year":"2025","unstructured":"Han J, Jeong H-J, Choi J, Kim H, Kwon T, Myung K, et al. Bioprinted patient-derived organoid arrays capture intrinsic and extrinsic tumor features for advanced personalized medicine. Adv Sci (Weinh)Adv Sci. 2025;12(20):12. https:\/\/doi.org\/10.1002\/advs.202407871.","journal-title":"Adv Sci (Weinh)Adv Sci"},{"issue":"10","key":"8763_CR283","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.heliyon.2023.e20475","volume":"9","author":"B Wu","year":"2023","unstructured":"Wu B, Wu Z-J, Hou Y-Y, Fang Z, Deng Y, Wu H-T, et al. Application of three-dimensional (3D) bioprinting in anti-cancer therapy. Heliyon. 2023;9(10):9. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20475.","journal-title":"Heliyon"},{"key":"8763_CR284","doi-asserted-by":"publisher","first-page":"150339","DOI":"10.1016\/j.bbrc.2024.150339","volume":"730","author":"Y Dong","year":"2024","unstructured":"Dong Y, Zhou X, Ding Y, Luo Y, Zhao H. Advances in tumor microenvironment: applications and challenges of 3D bioprinting. Biochem Bioph Res Co. 2024;730:150339. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150339.","journal-title":"Biochem Bioph Res Co"},{"issue":"6","key":"8763_CR285","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s42242-024-00317-y","volume":"7","author":"H Li","year":"2024","unstructured":"Li H, Qiao Y, Dai X, Tian H, Han Z, Cheng S, et al. 3D bioprinting of tumor models and potential applications. Bio-des. Manuf. 2024;7(6):857\u201388. https:\/\/doi.org\/10.1007\/s42242-024-00317-y.","journal-title":"Bio-des. Manuf"},{"issue":"1","key":"8763_CR286","doi-asserted-by":"publisher","first-page":"9751","DOI":"10.1038\/s41598-025-92037-1","volume":"15","author":"S Zhu","year":"2025","unstructured":"Zhu S, Yin J, Lu X, Jiang D, Chen R, Cui K, et al. Influence of experimental variables on spheroid attributes. Sci Rep. 2025;15(1):9751. https:\/\/doi.org\/10.1038\/s41598-025-92037-1.","journal-title":"Sci Rep"},{"key":"8763_CR287","doi-asserted-by":"publisher","unstructured":"Hachey SJ, Gaebler D, Hughes CCW. Establishing a physiologic human vascularized micro-tumor model for cancer research. J Visualized Experiments: JoVE. 2023;199(199):10.3791\/65865. https:\/\/doi.org\/10.3791\/65865.","DOI":"10.3791\/65865"},{"key":"8763_CR288","doi-asserted-by":"publisher","first-page":"122428","DOI":"10.1016\/j.biomaterials.2023.122428","volume":"305","author":"K Ravi","year":"2024","unstructured":"Ravi K, Manoharan TJM, Wang K-C, Pockaj B, Nikkhah M. Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment. Biomaterials. 2024;305:122428. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122428.","journal-title":"Biomaterials"},{"issue":"7","key":"8763_CR289","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","volume":"56","author":"L Thorel","year":"2024","unstructured":"Thorel L, Perr\u00e9ard M, Florent R, Divoux J, Coffy S, Vincent A, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med. 2024;56(7):1531\u201351. https:\/\/doi.org\/10.1038\/s12276-024-01272-5.","journal-title":"Exp Mol Med"},{"issue":"12","key":"8763_CR290","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.ccell.2022.09.017","volume":"40","author":"S Bose","year":"2022","unstructured":"Bose S, Barroso M, Chheda MG, Clevers H, Elez E, Kaochar S, et al. A path to translation: how 3D patient tumor avatars enable next generation precision oncology. Cancer Cell. 2022;40(12):1448\u201353. https:\/\/doi.org\/10.1016\/j.ccell.2022.09.017.","journal-title":"Cancer Cell"},{"issue":"1","key":"8763_CR291","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-025-03437-0","volume":"44","author":"P Navarro","year":"2025","unstructured":"Navarro P, Grazioso TP, Barqu\u00edn A, Barba M, Yag\u00fce M, Mill\u00e1n C, et al. Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids. J Exp Clin Cancer Res. 2025;44(1):182. https:\/\/doi.org\/10.1186\/s13046-025-03437-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"8763_CR292","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41420-025-02505-w","volume":"11","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yuan F, Zuo X, Li M. Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: a cutting-edge tool for advancing personalised treatments. Cell Death Discov. 2025;11(1):11. https:\/\/doi.org\/10.1038\/s41420-025-02505-w.","journal-title":"Cell Death Discov"},{"issue":"3","key":"8763_CR293","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1088\/1758-5090\/ac6d11","volume":"14","author":"P Shukla","year":"2022","unstructured":"Shukla P, Yeleswarapu S, Heinrich M, Prakash J, Pati F. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling. Biofabrication. 2022;14(3):14. https:\/\/doi.org\/10.1088\/1758-5090\/ac6d11.","journal-title":"Biofabrication"},{"issue":"2","key":"8763_CR294","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","volume":"19","author":"A Sontheimer-Phelps","year":"2019","unstructured":"Sontheimer-Phelps A, Hassell B, Ingber D. Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019;19(2):65\u201381. https:\/\/doi.org\/10.1038\/s41568-018-0104-6.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"8763_CR295","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1007\/s00262-023-03572-7","volume":"72","author":"M Chernyavska","year":"2023","unstructured":"Chernyavska M, Masoudnia M, Valerius T, Verdurmen W. Organ-on-a-chip models for development of cancer immunotherapies. ImmunotherapyCancer Immunol Immunother. 2023;72(12):3971\u201383. https:\/\/doi.org\/10.1007\/s00262-023-03572-7.","journal-title":"ImmunotherapyCancer Immunol Immunother"},{"issue":"1","key":"8763_CR296","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1186\/s12967-025-06824-5","volume":"23","author":"C Lin","year":"2025","unstructured":"Lin C, Zhang Z, Yang F, Gu S, Zuo J, Wu Y, et al. Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer. J Transl Med. 2025;23(1):798. https:\/\/doi.org\/10.1186\/s12967-025-06824-5.","journal-title":"J Transl Med"},{"key":"8763_CR297","doi-asserted-by":"publisher","first-page":"101750","DOI":"10.1016\/j.tranon.2023.101750","volume":"37","author":"P Gnatowski","year":"2023","unstructured":"Gnatowski P, Pi\u0142at E, Kuci\u0144ska-Lipka J, Saeb MR, Hamblin MR, Mozafari M. Recent advances in 3D bioprinted tumor models for personalized medicine. Transl Oncol. 2023;37:101750. https:\/\/doi.org\/10.1016\/j.tranon.2023.101750.","journal-title":"Transl Oncol"},{"issue":"1","key":"8763_CR298","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1242\/dmm.025049","volume":"10","author":"J Albritton","year":"2017","unstructured":"Albritton J, Miller J. 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. Disease Model Mechanisms. 2017;10(1):3\u201314. https:\/\/doi.org\/10.1242\/dmm.025049.","journal-title":"Disease Model Mechanisms"},{"issue":"7","key":"8763_CR299","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/polym17070948","volume":"17","author":"S Liu","year":"2025","unstructured":"Liu S, Jin P. Advances and challenges in 3D bioprinted cancer models: opportunities for personalized medicine and tissue engineering. Polymers. 2025;17(7):948. https:\/\/doi.org\/10.3390\/polym17070948.","journal-title":"Polymers"},{"key":"8763_CR300","doi-asserted-by":"publisher","unstructured":"Wolff L, Hendrix S. Rethinking Matrigel: the complex journey to matrix alternatives in organoid culture. Adv Sci (Weinh)Adv Sci. 2025;12(47):e08734. https:\/\/doi.org\/10.1002\/advs.202508734.","DOI":"10.1002\/advs.202508734"},{"issue":"1","key":"8763_CR301","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12967-025-06349-x","volume":"23","author":"K Li","year":"2025","unstructured":"Li K, He Y, Jin X, Jin K, Qian J. Reproducible extracellular matrices for tumor organoid culture: challenges and opportunities. J Transl Med. 2025;23(1):497. https:\/\/doi.org\/10.1186\/s12967-025-06349-x.","journal-title":"J Transl Med"},{"key":"8763_CR302","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bioactmat.2023.06.004","volume":"28","author":"Z Gan","year":"2023","unstructured":"Gan Z, Qin X, Liu H, Liu J, Qin J. Recent advances in defined hydrogels in organoid research. Bioact Mater. 2023;28:386\u2013401. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.06.004.","journal-title":"Bioact Mater"},{"key":"8763_CR303","doi-asserted-by":"publisher","first-page":"119400","DOI":"10.1016\/j.biomaterials.2019.119400","volume":"219","author":"S Ng","year":"2019","unstructured":"Ng S, Tan WJ, Pek MMX, Tan M-H, Kurisawa M. Mechanically and chemically defined hydrogel matrices for patient-derived colorectal tumor organoid culture. Biomaterials. 2019;219:119400. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119400.","journal-title":"Biomaterials"},{"issue":"11","key":"8763_CR304","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/gels11110855","volume":"11","author":"G Rijal","year":"2025","unstructured":"Rijal G, Park I-W. Dynamic hydrogels in breast tumor models. Gels. 2025;11(11):855. https:\/\/doi.org\/10.3390\/gels11110855.","journal-title":"Gels"},{"issue":"7","key":"8763_CR305","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/bioengineering11070664","volume":"11","author":"M De Spirito","year":"2024","unstructured":"De Spirito M, Palmieri V, Perini G, Papi M. Bridging the gap: integrating 3D bioprinting and Microfluidics for advanced multi-organ models in biomedical research. Bioeng (Basel, Switz). 2024;11(7):664. https:\/\/doi.org\/10.3390\/bioengineering11070664.","journal-title":"Bioeng (Basel, Switz)"},{"key":"8763_CR306","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.mtbio.2024.101198","volume":"28","author":"X Cui","year":"2024","unstructured":"Cui X, Jiao J, Yang L, Wang Y, Jiang W, Yu T, et al. Advanced tumor organoid bioprinting strategy for oncology research. Mater Today Bio. 2024;28:101198. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101198.","journal-title":"Mater Today Bio"},{"issue":"2","key":"8763_CR307","doi-asserted-by":"publisher","first-page":"682","DOI":"10.7150\/thno.105840","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Chen X, Li R, Wang S, Geng Z, Shi Z, et al. Standardization and consensus in the development and application of bone organoids. Theranostics. 2025;15(2):682. https:\/\/doi.org\/10.7150\/thno.105840.","journal-title":"Theranostics"},{"issue":"5","key":"8763_CR308","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","volume":"6","author":"M Hofer","year":"2021","unstructured":"Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater. 2021;6(5):402\u201320. https:\/\/doi.org\/10.1038\/s41578-021-00279-y.","journal-title":"Nat Rev Mater"},{"issue":"6","key":"8763_CR309","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.stemcr.2023.05.009","volume":"18","author":"KB Jensen","year":"2023","unstructured":"Jensen KB, Little MH. Organoids are not organs: sources of variation and misinformation in organoid biology. STEM Cell Rep. 2023;18(6):1255\u201370. https:\/\/doi.org\/10.1016\/j.stemcr.2023.05.009.","journal-title":"STEM Cell Rep"},{"issue":"1","key":"8763_CR310","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s44385-025-00054-6","volume":"3","author":"D Kim","year":"2026","unstructured":"Kim D, Youn J, Kim J, Lee J, Yoon J, Kim DS. From organoid culture to manufacturing: technologies for reproducible and scalable organoid production. Npj Biomed Innov. 2026;3(1):12. https:\/\/doi.org\/10.1038\/s44385-025-00054-6.","journal-title":"Npj Biomed Innov"},{"key":"8763_CR311","doi-asserted-by":"publisher","first-page":"119547","DOI":"10.1016\/j.biomaterials.2019.119547","volume":"229","author":"Y Nashimoto","year":"2020","unstructured":"Nashimoto Y, Okada R, Hanada S, Arima Y, Nishiyama K, Miura T, et al. Vascularized cancer on a chip: the effect of perfusion on growth and drug delivery of tumor spheroid. Biomaterials. 2020;229:119547. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119547.","journal-title":"Biomaterials"},{"issue":"23","key":"8763_CR312","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1039\/C8LC00596F","volume":"18","author":"VS Shirure","year":"2018","unstructured":"Shirure VS, Bi Y, Curtis MB, Lezia A, Goedegebuure MM, Goedegebuure SP, et al. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. Lab Chip. 2018;18(23):3687\u2013702. https:\/\/doi.org\/10.1039\/C8LC00596F.","journal-title":"Lab Chip"},{"key":"8763_CR313","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fbioe.2019.00039","volume":"7","author":"S Grebenyuk","year":"2019","unstructured":"Grebenyuk S, Ranga A. Engineering organoid vascularization. Frontiers in bioengineering and biotechnology. 2019. Front Bioeng Biotechnol. 2019;7:39. https:\/\/doi.org\/10.3389\/fbioe.2019.00039.","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"8763_CR314","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41592-019-0325-y","volume":"16","author":"KA Homan","year":"2019","unstructured":"Homan KA, Gupta N, Kroll KT, Kolesky DB, Skylar-Scott M, Miyoshi T, et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat Methods. 2019;16(3):255\u201362. https:\/\/doi.org\/10.1038\/s41592-019-0325-y.","journal-title":"Nat Methods"},{"issue":"7","key":"8763_CR315","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nprot.2012.051","volume":"7","author":"Y Shin","year":"2012","unstructured":"Shin Y, Han S, Jeon JS, Yamamoto K, Zervantonakis IK, Sudo R, et al. Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels. Nat Protoc. 2012;7(7):1247\u201359. https:\/\/doi.org\/10.1038\/nprot.2012.051.","journal-title":"Nat Protoc"},{"issue":"7","key":"8763_CR316","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175(7):1972\u201388. e16. https:\/\/doi.org\/10.1016\/j.cell.2018.11.021.","journal-title":"Cell"},{"issue":"2","key":"8763_CR317","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","volume":"8","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, et al. Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids. Cancer DiscovCancer Discov. 2018;8(2):196\u2013215. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0833.","journal-title":"Cancer DiscovCancer Discov"},{"key":"8763_CR318","doi-asserted-by":"publisher","unstructured":"Ayuso JM, Rehman S, Virumbrales-Munoz M, McMinn PH, Geiger P, Fitzgerald C, et al. Microfluidic tumor-on-a-chip model to evaluate the role of tumor environmental stress on NK cell exhaustion. Sci Adv. 2021;7(8):eabc 2331. https:\/\/doi.org\/10.1126\/sciadv.abc2331.","DOI":"10.1126\/sciadv.abc2331"},{"issue":"4","key":"8763_CR319","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/organoids4040030","volume":"4","author":"E Heinzelmann","year":"2025","unstructured":"Heinzelmann E, Piraino F. AI-Enhanced patient-derived cancer organoids: integrating machine learning for precision oncology. Organoids. 2025;4(4):30. https:\/\/doi.org\/10.3390\/organoids4040030.","journal-title":"Organoids"},{"issue":"35","key":"8763_CR320","doi-asserted-by":"publisher","first-page":"49210","DOI":"10.1021\/acsami.5c10049","volume":"17","author":"H Jeon","year":"2025","unstructured":"Jeon H, Kim G, Carpenter J, Col\u00f3n YJ, Wang WYA. Automated high-content, high-throughput spatial analysis pipeline for drug screening in 3D tumor spheroid inverted colloidal crystal arrays. ACS Appl. Mater. Interface. 2025;17(35):49210\u201326. https:\/\/doi.org\/10.1021\/acsami.5c10049.","journal-title":"ACS Appl. Mater. Interface"},{"key":"8763_CR321","doi-asserted-by":"publisher","first-page":"100820","DOI":"10.1016\/j.mtbio.2023.100820","volume":"23","author":"TKN Ngo","year":"2023","unstructured":"Ngo TKN, Yang SJ, Mao B-H, Nguyen TKM, Ng QD, Kuo Y-L, et al. A deep learning-based pipeline for analyzing the influences of interfacial mechanochemical microenvironments on spheroid invasion using differential interference contrast microscopic images. Mater Today Bio. 2023;23:100820. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100820.","journal-title":"Mater Today Bio"},{"issue":"13","key":"8763_CR322","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u201387. e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"issue":"1","key":"8763_CR323","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, Marioni JC, et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21(1):111. https:\/\/doi.org\/10.1186\/s13059-020-02015-1.","journal-title":"Genome Biol"},{"issue":"1","key":"8763_CR324","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-023-01916-6","volume":"23","author":"A Jose","year":"2024","unstructured":"Jose A, Kulkarni P, Thilakan J, Munisamy M, Malhotra AG, Singh J, et al. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine. Mol Cancer. 2024;23(1):50. https:\/\/doi.org\/10.1186\/s12943-023-01916-6.","journal-title":"Mol Cancer"},{"key":"8763_CR325","doi-asserted-by":"publisher","first-page":"771173","DOI":"10.3389\/fonc.2021.771173","volume":"11","author":"ER Spiller","year":"2021","unstructured":"Spiller ER, Ung N, Kim S, Patsch K, Lau R, Strelez C, et al. Imaging-based machine learning analysis of patient-derived tumor organoid drug response. Front Oncol. 2021;11:771173. https:\/\/doi.org\/10.3389\/fonc.2021.771173.","journal-title":"Front Oncol"},{"issue":"1","key":"8763_CR326","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","volume":"12","author":"B Bj\u00f6rnsson","year":"2020","unstructured":"Bj\u00f6rnsson B, Borrebaeck C, Elander N, Gasslander T, Gawel DR, Gustafsson M, et al. Digital twins to personalize medicine. Genome Med. 2020;12(1):4. https:\/\/doi.org\/10.1186\/s13073-019-0701-3.","journal-title":"Genome Med"},{"key":"8763_CR327","doi-asserted-by":"publisher","first-page":"107742","DOI":"10.1016\/j.oraloncology.2025.107742","volume":"171","author":"R Doerfler","year":"2025","unstructured":"Doerfler R, Chen J, Kim C, Smith JD, Harris M, Singh KB, et al. Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer. Oral Oncol. 2025;171:107742. https:\/\/doi.org\/10.1016\/j.oraloncology.2025.107742.","journal-title":"Oral Oncol"},{"issue":"9","key":"8763_CR328","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.4389","volume":"23","author":"A Letai","year":"2017","unstructured":"Letai A. Functional precision cancer medicine\u2014moving beyond pure genomics. Nat Med. 2017;23(9):1028\u201335. https:\/\/doi.org\/10.1038\/nm.4389.","journal-title":"Nat Med"},{"key":"8763_CR329","doi-asserted-by":"publisher","unstructured":"Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019;11(513):eaay 2574. https:\/\/doi.org\/10.1126\/scitranslmed.aay2574.","DOI":"10.1126\/scitranslmed.aay2574"},{"issue":"10","key":"8763_CR330","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Wu C, O\u2019Rourke KP, Szeglin BC, Zheng Y, Sauv\u00e9 C-EG, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25(10):1607\u201314. https:\/\/doi.org\/10.1038\/s41591-019-0584-2.","journal-title":"Nat Med"},{"issue":"3","key":"8763_CR331","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ame2.12077","volume":"2","author":"LM Granat","year":"2019","unstructured":"Granat LM, Kambhampati O, Klosek S, Niedzwecki B, Parsa K, Zhang D. The promises and challenges of patient-derived tumor organoids in drug development and precision oncology. Anim Model Exp Med. 2019;2(3):150\u201361. https:\/\/doi.org\/10.1002\/ame2.12077.","journal-title":"Anim Model Exp Med"},{"issue":"3","key":"8763_CR332","doi-asserted-by":"publisher","first-page":"365","DOI":"10.14573\/altex.2001241","volume":"37","author":"U Marx","year":"2020","unstructured":"Marx U, et al. Biology-inspired microphysiological systems to advance medicines for patient benefit and animal welfare. Altex. 2020;37(3):365. https:\/\/doi.org\/10.14573\/altex.2001241.","journal-title":"Altex"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08763-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:51:48Z","timestamp":1788879108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08763-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":332,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8763"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08763-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1156"}}